Huron Consulting (HURN) 10-K 25 Feb 25 2024 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2024	Feb. 18, 2025	Jun. 30, 2024
Cover [Abstract]
Document Type	10-K
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2024
Document Transition Report	false
Entity File Number	000-50976
Entity Registrant Name	HURON CONSULTING GROUP INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	01-0666114
Entity Address, Address Line One	550 West Van Buren Street
Entity Address, City or Town	Chicago
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60607
City Area Code	(312)
Local Phone Number	583-8700
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	HURN
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 1,706,000,000
Entity Common Stock, Shares Outstanding		17,677,584
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001289848
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2024
Auditor [Line Items]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	Chicago, Illinois
Auditor Firm ID	238

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 21,911	$ 12,149
Receivables from clients, net of allowances of $11,575 and $17,284, respectively	197,771	162,566
Costs in Excess of Billings, Current	160,017	190,869
Income tax receivable	1,355	6,385
Prepaid expenses and other current assets	28,063	28,491
Total current assets	409,117	400,460
Property and equipment, net	21,678	23,728
Deferred income taxes, net	2,546	2,288
Long-term investments	69,712	75,414
Operating lease right-of-use assets	19,176	24,131
Other non-current assets	116,569	92,336
Intangible assets, net	26,076	18,074
Goodwill	678,743	625,711
Total assets	1,343,617	1,262,142
Current liabilities:
Accounts payable	11,539	10,074
Accrued expenses and other current liabilities	26,768	33,087
Accrued payroll and related benefits	247,579	225,921
Current maturities of long-term debt	13,750	0
Current maturities of operating lease liabilities	12,315	11,032
Deferred revenues	26,869	22,461
Total current liabilities	338,820	302,575
Non-current liabilities:
Deferred compensation and other liabilities	42,481	35,665
Long-term debt, net of current portion	342,857	324,000
Operating lease liabilities, net of current portion	29,686	38,850
Deferred income taxes, net	28,446	28,160
Total non-current liabilities	443,470	426,675
Commitments and contingencies
Stockholders’ equity
Common Stock, Value, Issued	208	212
Treasury Stock, Value	160,093	142,136
Additional paid-in capital	177,673	236,962
Retained earnings	531,653	415,027
Accumulated other comprehensive income	11,886	22,827
Total stockholders’ equity	561,327	532,892
Total liabilities and stockholders’ equity	$ 1,343,617	$ 1,262,142

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Accounts Receivable, Allowance for Credit Loss, Current	$ 11,575	$ 17,284
Unbilled Services, Allowance for Credit Losses	$ 2,203	$ 5,984
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	20,780,928	21,316,441
Treasury Stock, Common, Shares	3,065,633	2,852,296

Consolidated Statements of Earn

Consolidated Statements of Earnings and Other Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues and reimbursable expenses:
Revenues before reimbursable expenses	$ 1,486,085	$ 1,362,060	$ 1,132,455
Reimbursable expenses	35,720	36,695	26,506
Total revenues	1,521,805	1,398,755	1,158,961
Direct Operating Costs [Abstract]
Direct costs (exclusive of depreciation and amortization included below)	1,010,077	942,697	785,881
Reimbursable expenses	35,715	36,766	26,671
Selling, general and administrative expenses	286,655	257,932	209,574
Other gains, net	(14,196)	(444)	(193)
Restructuring charges	9,913	11,550	9,909
Depreciation and amortization	24,822	24,906	27,359
Total operating expenses	1,352,986	1,273,407	1,059,201
Operating income	168,819	125,348	99,760
Other income (expense), net
Interest expense, net of interest income	(25,347)	(19,573)	(11,883)
Other income (expense), net	10,544	(21,880)	20,700
Total other income (expense), net	(14,803)	(41,453)	8,817
Income before taxes	154,016	83,895	108,577
Income tax expense	37,390	21,416	33,025
Net income	$ 116,626	$ 62,479	$ 75,552
Net earnings per basic share:
Net income per basic share	$ 6.52	$ 3.32	$ 3.73
Net income per diluted share	$ 6.27	$ 3.19	$ 3.64
Weighted average shares used in calculating earnings per share:
Basic	17,894	18,832	20,249
Diluted	18,613	19,601	20,746
Comprehensive income
Net income	$ 116,626	$ 62,479	$ 75,552
Foreign currency translation adjustments, net of tax	(3,391)	512	(1,890)
Unrealized gain (loss) on investment, net of tax	(4,177)	7,811	(6,146)
Unrealized gain (loss) on cash flow hedging instruments, net of tax	(3,373)	(3,615)	9,315
Other comprehensive income (loss)	(10,941)	4,708	1,279
Comprehensive income	$ 105,685	$ 67,187	$ 76,831

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Treasury Stock, Common	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Beginning balance, shares at Dec. 31, 2021		(23,868,918)	(2,908,849)
Beginning balance at Dec. 31, 2021	$ 571,900	$ 239	$ (135,969)	$ 413,794	$ 276,996	$ 16,840
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	76,831				75,552	1,279
Restricted stock awards, net of cancellations, shares		(363,891)	109,548
Restricted stock awards, net of cancellations	0	$ 4	$ 6,208	(6,212)
Exercise of stock options, shares		36,536
Stock Issued During Period, Value, Stock Options Exercised	1,421	$ 0		1,421
Share-based compensation	30,991			30,991
Shares redeemed for employee tax withholdings, shares			(153,846)
Shares redeemed for employee tax withholdings	(7,795)		$ (7,795)
Share repurchases, shares		(2,037,752)
Share repurchases	(121,308)	$ (20)		(121,288)
Ending balance, shares at Dec. 31, 2022		(22,231,593)	(2,953,147)
Ending balance at Dec. 31, 2022	552,040	$ 223	$ (137,556)	318,706	352,548	18,119
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	67,187				62,479	4,708
Restricted stock awards, net of cancellations, shares		(338,173)	124,216
Restricted stock awards, net of cancellations	0	$ 3	$ 5,956	(5,959)
Exercise of stock options, shares		51,266
Stock Issued During Period, Value, Stock Options Exercised	2,524	$ 1		2,523
Stock Issued During Period, Shares, Acquisitions		16,337
Stock Issued During Period, Value, Acquisitions	1,646	$ 0		1,646
Share-based compensation	43,658			43,658
Shares redeemed for employee tax withholdings, shares			(146,390)
Shares redeemed for employee tax withholdings	(10,536)		$ (10,536)
Share repurchases, shares		(1,461,815)
Share repurchases	(123,627)	$ (15)		(123,612)
Ending balance, shares at Dec. 31, 2023		(21,175,554)	(2,975,321)
Ending balance at Dec. 31, 2023	532,892	$ 212	$ (142,136)	236,962	415,027	22,827
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	105,685				116,626	(10,941)
Restricted stock awards, net of cancellations, shares		(587,152)	81,446
Restricted stock awards, net of cancellations	0	$ 6	$ 4,128	(4,134)
Exercise of stock options, shares		32,986
Stock Issued During Period, Value, Stock Options Exercised	1,832	$ 0		1,832
Stock Issued During Period, Shares, Acquisitions		185,069
Stock Issued During Period, Value, Acquisitions	20,851	$ 2		20,849
Share-based compensation	44,237			44,237
Shares redeemed for employee tax withholdings, shares			(223,800)
Shares redeemed for employee tax withholdings	(22,085)		$ (22,085)
Share repurchases, shares		(1,218,434)
Share repurchases	(122,198)	$ (12)		(122,186)
Ending balance, shares at Dec. 31, 2024		(20,762,327)	(3,117,675)
Ending balance at Dec. 31, 2024	561,327	$ 208	$ (160,093)	177,673	$ 531,653	$ 11,886
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Adjustments to Additional Paid in Capital, Other	$ 113			$ 113

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income	$ 116,626	$ 62,479	$ 75,552
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	25,300	24,938	27,359
Non-cash lease expense	6,065	6,321	6,369
Lease-related impairment charges	3,513	6,248	211
Share-based compensation	45,074	45,697	30,971
Amortization of debt discount and issuance costs	1,078	769	1,169
Allowances for doubtful accounts	3,073	421	141
Deferred income taxes	2,613	(6,182)	18,784
Gain on sale of property and equipment, excluding transaction costs	(101)	(64)	(1,111)
Gain on sale of businesses, excluding transaction costs	(4,309)	0	0
Change in fair value of contingent consideration liabilities	533	490	359
Change in fair value of preferred stock investment	0	26,262	(26,964)
Other, net	0	0	6
Changes in operating assets and liabilities, net of acquisitions and divestiture:
(Increase) decrease in receivables from clients, net	(30,496)	(15,046)	(25,847)
(Increase) decrease in unbilled services, net	31,123	(49,051)	(51,359)
(Increase) decrease in current income tax receivable / payable, net	5,412	(5,139)	7,673
(Increase) decrease in other assets	(8,153)	(6,535)	2,532
Increase (decrease) in accounts payable and other liabilities	(12,228)	(6,948)	(13,466)
Increase (decrease) in accrued payroll and related benefits	16,370	51,022	32,770
Increase (decrease) in deferred revenues	892	560	969
Net cash provided by operating activities	201,319	135,262	85,400
Cash flows from investing activities:
Purchases of property and equipment	(8,651)	(9,444)	(12,547)
Investments in life insurance policies	(2,594)	(3,074)	(872)
Distributions from life insurance policies	0	2,956	3,377
Purchases of businesses, net of cash acquired	(49,503)	(1,613)	(3,448)
Capitalization of internally developed software costs	(23,932)	(25,742)	(11,752)
Proceeds from note receivable	154	154	154
Proceeds from sale of property and equipment	102	111	4,753
Proceeds from divestitures of businesses	4,675	0	207
Net cash used in investing activities	(79,749)	(36,652)	(20,128)
Cash flows from financing activities:
Proceeds from exercises of stock options	1,832	2,524	1,421
Shares redeemed for employee tax withholdings	(22,085)	(10,536)	(7,795)
Share repurchases	(123,006)	(122,757)	(120,393)
Proceeds from bank borrowings	743,500	354,000	314,000
Repayments of bank borrowings	(709,813)	(320,000)	(256,780)
Payments for debt issuance costs	(1,446)	(58)	(2,686)
Deferred payments on business acquisition	617	1,500	1,875
Net cash used in financing activities	(111,635)	(98,327)	(74,108)
Effect of exchange rate changes on cash	(173)	32	(111)
Net increase (decrease) in cash and cash equivalents	9,762	315	(8,947)
Cash and cash equivalents at end of the period	21,911	12,149	11,834
Cash and cash equivalents at beginning of the period	12,149	11,834	20,781
Non-cash investing and financing activities:
Property and equipment expenditures and capitalized software included in current liabilities	5,016	5,156	3,784
Common stock issued related to purchases of businesses	20,851	1,646	0
Contingent consideration accrued related to purchases of businesses	36	374	1,185
Notes Issued	2,250	0	0
Share Repurchases Initiated but not yet Settled	636	1,030	1,107
Excise tax on net share repurchases incurred but not paid [Abstract]	533	947
Cash paid during the year for:
Interest	33,319	27,006	12,246
Income taxes	$ 30,152	$ 33,849	$ 13,485

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements reflect the financial position at December 31, 2024 and 2023, and the results of operations and cash flows for the years ended December 31, 2024, 2023, and 2022. The consolidated financial statements include the accounts of Huron Consulting Group Inc. and its subsidiaries, all of which are wholly-owned. All intercompany balances and transactions have been eliminated in consolidation. In the second quarter of 2024, we revised the presentation of our consolidated statement of operations and other comprehensive income (loss) to separately present other gains, net previously presented within selling, general and administrative expenses. The change in presentation had no effect on our consolidated results, and our historical consolidated statements of operations and other comprehensive income (loss) were revised for consistent presentation. In the third quarter of 2024, we revised the line item descriptions of revenues to rename revenues as revenues before reimbursable expenses and to rename total revenues and reimbursable expenses as total revenues. The change in line item description has no impact on the line item totals for any periods presented. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts that are reported in the consolidated financial statements and accompanying disclosures. Actual results may differ from these estimates and assumptions. Revenue Recognition We generate substantially all of our revenues from providing professional services to our clients. We also generate revenues from software licenses; software support and maintenance and subscriptions to our cloud-based analytic tools and solutions; speaking engagements; conferences; and publications. A single contract could include one or multiple performance obligations. For those contracts that have multiple performance obligations, we allocate the total transaction price to each performance obligation based on its relative standalone selling price, which is determined based on our overall pricing objectives, taking into consideration market conditions and other factors. Revenue is recognized when control of the goods and services provided are transferred to our customers and in an amount that reflects the consideration we expect to be entitled to in exchange for those goods and services using the following steps: 1) identify the contract, 2) identify the performance obligations, 3) determine the transaction price, 4) allocate the transaction price to the performance obligations in the contract, and 5) recognize revenue as or when we satisfy the performance obligations. We generate our revenues under four types of billing arrangements: fixed-fee (including software license revenue); time-and-expense; performance-based; and software support, maintenance and subscriptions. • Fixed-fee (including software license revenue): In fixed-fee billing arrangements, we agree to a pre-established fee in exchange for a predetermined set of professional services. We set the fees based on our estimates of the costs and timing for completing the engagements. We generally recognize revenues under fixed-fee billing arrangements using a proportionate performance approach, which is based on work completed to date versus our estimates of the total services to be provided under the engagement. Contracts within our culture and organizational excellence solution include fixed-fee partner contracts with multiple performance obligations, which primarily consist of coaching services, as well as speaking engagements, conferences, publications and software products (“Partner Contracts”). Revenues for coaching services and software products are generally recognized on a straight-line basis over the length of the contract. All other revenues under Partner Contracts, including speaking engagements, conferences and publications, are recognized at the time the goods or services are provided. Estimates of total engagement revenues and cost of services are monitored regularly during the term of the engagement. We also generate revenues from software licenses for our research administration and compliance software, which is generally recognized in the month in which the software is delivered. • Time-and-expense: Under time-and-expense billing arrangements, we invoice our clients based on the number of hours worked by our revenue-generating professionals at agreed upon rates. Time-and-expense arrangements also include certain speaking engagements, conferences, and publications purchased by our clients outside of Partner Contracts within our culture and organizational excellence solution and the portion of our Healthcare managed services contracts that are billed under time-and-expense arrangements. We recognize revenues under time-and-expense arrangements as the related services or publications are provided, using the right to invoice practical expedient which allows us to recognize revenue in the amount that we have a right to invoice based on the number of hours worked and the agreed upon hourly rates or the value of the speaking engagements, conferences or publications purchased by our clients. • Performance-based: In performance-based billing arrangements, fees are tied to the attainment of contractually defined objectives. We enter into performance-based engagements in essentially two forms. First, we generally earn fees that are directly related to the savings formally acknowledged by the client as a result of adopting our recommendations for improving operational and cost effectiveness in the areas we review. Second, we earn a success fee when and if certain predefined outcomes occur. We recognize revenue under performance-based billing arrangements using the following steps: 1) estimate variable consideration using either the expected value method or the most likely amount method, as appropriate 2) apply a constraint to the estimated variable consideration to limit the amount that could be reversed when the uncertainty is resolved (the “constraint”), and 3) recognize revenue of estimated variable consideration, net of the constraint, based on work completed to date versus our estimates of the total services to be provided under the engagement. • Software support, maintenance and subscriptions: Clients that have purchased one of our software licenses can pay an annual fee for software support and maintenance. We also generate subscription revenue from our cloud-based analytic tools and solutions including our cloud-based revenue cycle management software and research administration and compliance software. Software support, maintenance and subscription revenues are recognized ratably over the support or subscription period. These fees are generally billed in advance and included in deferred revenues until recognized. Provisions are recorded for the estimated realization adjustments on all engagements, including engagements for which fees are subject to review by the bankruptcy courts. Reimbursable expenses that are billed to clients, primarily relating to travel and out-of-pocket expenses incurred in connection with client engagements, are included in total revenues and reimbursable expenses. Reimbursable expenses are recognized as expenses in the period in which the expense is incurred. The payment terms and conditions in our customer contracts vary. Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenues in the consolidated balance sheets. Revenues recognized for services performed but not yet billed to clients are recorded as unbilled services. Revenues recognized, but for which we are not yet entitled to bill because certain events, such as the completion of the measurement period or client approval, must occur, are recorded as contract assets and included within unbilled services. Client prepayments and retainers are classified as deferred revenues and recognized over future periods as earned in accordance with the applicable engagement agreement. Capitalized Sales Commissions Sales commissions earned by our sales professionals are considered incremental and recoverable costs of obtaining a contract with a customer. Sales commissions with an expected amortization period greater than one year are deferred and amortized on a systematic basis that is consistent with the revenue recognition model for the associated contract. We elected to apply the practical expedient to expense sales commissions as incurred when the expected amortization period is one year or less. Amortization expense is recorded to direct costs. During the years ended December 31, 2024, 2023, and 2022, we amortized $0.3 million, $0.2 million, and $0.3 million, respectively, of capitalized sales commissions. Unamortized sales commissions were $0.5 million and $0.4 million as of December 31, 2024 and 2023, respectively. Allowances for Doubtful Accounts and Unbilled Services We maintain allowances for doubtful accounts and unbilled services based on several factors, including the estimated cash realization from amounts due from clients, an assessment of a client’s ability to make required payments, and the historical percentages of fee adjustments and write-offs by age of receivables and unbilled services. The allowances are assessed by management on a regular basis. These estimates may differ from actual results. If the financial condition of a client deteriorates in the future, impacting the client’s ability to make payments, an increase to our allowance might be required or our allowance may not be sufficient to cover actual write-offs. We record the provision for doubtful accounts and unbilled services as a reduction in revenue. To the extent we write-off accounts receivable due to a client's inability to pay, the charge is recognized as a component of selling, general and administrative expenses. Direct Costs Direct costs primarily consist of payroll costs for our revenue-generating professionals which includes salaries, performance bonuses, share-based compensation, signing and retention bonuses, payroll taxes and benefits. Direct costs also include fees paid to independent contractors that we retain to supplement our revenue-generating professionals, typically on an as-needed basis for specific client engagements, as well as technology costs, product and event costs, and commissions. Direct costs exclude reimbursable expenses and amortization of intangible assets and software development costs, both of which are separately presented in our consolidated statements of operations. Direct costs are expensed in the period incurred. Cash and Cash Equivalents We consider all highly liquid investments, including overnight investments and commercial paper, with original maturities of three months or less to be cash equivalents. Concentrations of Credit Risk To the extent receivables from clients become delinquent, collection activities commence. No single client balance is considered large enough to pose a material credit risk. The allowances for doubtful accounts and unbilled services are based upon the expected ability to collect accounts receivable and bill and collect unbilled services. Management does not anticipate incurring losses on accounts receivable in excess of established allowances. See Note 19 “Segment Information” for concentration of accounts receivable and unbilled services. We hold our cash in accounts at multiple third-party financial institutions. These deposits, at times, may exceed federally insured limits. We review the credit ratings of these financial institutions, regularly monitor the cash balances in these accounts, and adjust the balances as appropriate. However, these cash balances could be impacted if the underlying financial institutions fail or are subject to other adverse conditions in the financial markets. Long-term Investments Our long-term investments consist of our convertible debt investment in Shorelight Holdings, LLC (“Shorelight”) and preferred stock investment in a hospital-at-home company. We classified the convertible debt investment in Shorelight as available-for-sale at the time of purchase and reevaluate such classification as of each balance sheet date. The investment is carried at fair value with unrealized holding gains and losses reported in other comprehensive income. If the investment is in an unrealized loss position due to significant credit deterioration of the investee, we recognize an allowance to decrease the carrying value of the investment to the fair value, which may be reversed in the event that the credit of an issuer improves. In the event there are realized gains and losses or credit allowances recognized, we will record the amount in earnings. We have not realized any gains or losses or recognized any credit allowance on our convertible debt investment as of December 31, 2024. See Note 13 “Fair Value of Financial Instruments” for additional information on our convertible debt investment. We classified the preferred stock investment in the hospital-at-home company as an equity security without a readily determinable value at the time of purchase and reevaluate such classification as of each balance sheet date. We elected to apply the measurement alternative at the time of purchase and will continue to do so until the investment does not qualify to be so measured. Under the measurement alternative, the investment is carried at cost minus impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment in the company. On a quarterly basis, we review the information available to determine whether an orderly and observable transaction for the same or similar equity instrument occurred or if factors indicate that a significant decrease in value has occurred. We remeasure to the fair value of the preferred stock using such identified information with changes in the fair value recorded in our consolidated statement of operations. See Note 13 “Fair Value of Financial Instruments” for additional information on our preferred stock investment, including the cumulative unrealized gains recognized since our initial investment and the impairment loss recognized in 2023. Fair Value of Financial Instruments See Note 13 “Fair Value of Financial Instruments” for the accounting policies used to measure the fair value of our financial assets and liabilities that are measured at fair value on a recurring basis. Property and Equipment Property and equipment is recorded at cost, less accumulated depreciation, and depreciated using the straight-line method over the shorter of the estimated useful life of the asset or the lease term. Software, computers, and related equipment are depreciated over a useful life of two Leases We determine if an arrangement contains a lease and the classification of such lease at inception. As of December 31, 2024 and 2023, all of our material leases are classified as operating leases; we have not entered into any material finance leases. For all operating leases with an initial term greater than 12 months, we recognize an operating lease right-of-use (“ROU”) asset and operating lease liability. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. Operating lease ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the lease commencement date and provided by the administrative agent for our senior secured credit facility in determining the present value of lease payments. Operating lease ROU assets exclude lease incentives. We elected the practical expedient to combine lease and nonlease components. Certain lease agreements contain variable lease payments that do not depend on an index or rate. These variable lease payments are not included in the calculation of the operating lease ROU asset and operating lease liability; instead, they are expensed as incurred. Our leases may contain options to extend or terminate the lease, and we include these terms in our calculation of the operating lease ROU asset and operating lease liability when it is reasonably certain that we will exercise the option. Operating lease expense is recognized on a straight-line basis over the lease term and recorded within selling, general and administrative expenses on our consolidated statement of operations. In accordance with our accounting policy for impairment of long-lived assets, operating lease ROU assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset group to which the operating lease ROU asset is assigned may not be recoverable. We evaluate the recoverability of the asset group based on forecasted undiscounted cash flows. See Note 5 “Leases” for additional information on our leases, including the lease impairment charges recorded in 2024, 2023 and 2022. Software Development Costs We capitalize internal and external software development costs related to our cloud computing applications and software for internal use, which we account for in accordance with ASC 350-40: Intangibles - Goodwill and Other, Internal-Use Software; and related to software products that will be sold, leased, or marketed, which we account for in accordance with ASC 985: Software-Costs of Software to be Sold, Leased, or Marketed. These capitalized costs are included as a component of other non-current assets on our consolidated balance sheet and the related amortization is recorded to depreciation and amortization on our consolidated statements of operations. Under ASC 350-40, we capitalize software development costs incurred during the application development stage. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Once the project is substantially complete and ready for its intended use, these costs are amortized on a straight-line basis over the technology's estimated useful life. Acquired technology assets are initially recorded at fair value and amortized on a straight-line basis over the estimated useful life. As of December 31, 2024, gross capitalized internal-use software development costs and related accumulated amortization was $94.3 million and $33.8 million, respectively. As of December 31, 2023, gross capitalized internal-use software development costs and related accumulated amortization was $72.3 million and $26.8 million, respectively. During the years ended December 31, 2024, 2023, and 2022, we amortized $7.6 million, $6.5 million, and $5.9 million, respectively, of such software development costs. Under ASC 985, software development costs are expensed until technological feasibility has been established. Thereafter, and until the software is available for general release to customers, these software development costs are capitalized and subsequently reported at the lower of unamortized cost or net realizable value. These capitalized development costs are amortized in proportion to current and future revenue for each product with an annual minimum equal to the straight-line amortization over the remaining estimated economic life of the product. As of December 31, 2024, gross capitalized software development costs related to software products that will be sold, leased or otherwise marketed and related accumulated amortization was $0.7 million and $0.1 million, respectively. During the year ended December 31, 2024, we amortized $0.1 million of such capitalized costs. We did not capitalize any material development costs for this type of software during 2023. Implementation Costs Incurred in a Cloud Computing Arrangement We incur costs to implement cloud computing arrangements that are service contracts. We capitalize certain costs associated with the implementation of the cloud computing arrangements, including employee payroll and related benefits and third party consulting costs, incurred during the application development stage of a project. These costs are amortized on a straight-line basis over the term of the hosting service contracts, including renewal periods we are reasonably certain to exercise, and recognized as a component of selling, general and administrative expenses on our consolidated statement of operations. As of December 31, 2024, gross capitalized implementation costs incurred in a cloud computing arrangement and related accumulated amortization was $7.7 million and $3.0 million, respectively. As of December 31, 2023, gross capitalized implementation costs incurred in a cloud computing arrangement and related accumulated amortization was $7.2 million and $2.2 million, respectively. During the years ended December 31, 2024, 2023 and 2022 we recognized amortization of our capitalized implementation costs of $0.8 million, $0.7 million and $1.2 million, respectively. Of the $1.2 million amortization for capitalized implementation costs in 2022, $0.3 million was recognized as a restructuring charge as it related to accelerated amortization of capitalized software implementation costs for a cloud-computing arrangement that is no longer in use. Our capitalized implementation costs primarily relate to the implementation of a new ERP system. In January 2021, we successfully went live with the new ERP system, and we continue to progress with additional functionality and integrations as scheduled. These capitalized costs are included as a component of prepaid expenses and other current assets and other non-current assets on our consolidated balance sheet. Intangible Assets Other Than Goodwill Identifiable intangible assets are amortized over their expected useful lives using a method that reflects the economic benefit expected to be derived from the assets or on a straight-line basis. We evaluate the recoverability of intangible assets periodically by considering events or circumstances that may warrant revised estimates of useful lives or that indicate the asset may be impaired. Impairment of Long-Lived Assets Long-lived assets, including property and equipment, right-of-use assets, and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a significant decline in forecasted operating results over an extended period of time. We evaluate the recoverability of long-lived assets based on forecasted undiscounted cash flows. See Note 5 “Leases” and Note 11 “Restructuring Charges” for information on our operating lease ROU asset impairment charges recorded in 2024, 2023, 2022 and fixed asset impairment charges recorded in 2024 and 2023. No material impairment charges for other long-lived assets were recorded in 2024, 2023, or 2022. Goodwill For acquisitions accounted for as a business combination, goodwill represents the excess of the cost over the fair value of the net assets acquired. We are required to test goodwill for impairment, at the reporting unit level, annually and when events or circumstances indicate the fair value of a reporting unit may be below its carrying value. We perform our annual goodwill impairment test as of November 30 and monitor for interim triggering events on an ongoing basis. A reporting unit is an operating segment or one level below an operating segment (referred to as a component) to which goodwill is assigned when initially recorded. We assign goodwill to reporting units based on our integration plans and the expected synergies resulting from the acquisition. As of December 31, 2024, we have three reporting units: Healthcare, Education, and Commercial. In 2024, we performed the annual goodwill impairment test as of November 30, 2024, pursuant to our policy, and determined that no impairment of goodwill existed as of that date. Further, we evaluated whether any events have occurred, or any circumstances have changed since November 30, 2024 that would indicate goodwill may have become impaired since our annual impairment test. Based on our evaluation as of December 31, 2024, we determined that no indications of impairment have arisen since our annual goodwill impairment test. In 2023, we performed the annual goodwill impairment test as of November 30, 2023, pursuant to our policy, and determined that no impairment of goodwill existed as of that date. In 2022, we performed two goodwill impairment tests: an interim impairment test for each of our reporting units as of January 1, 2022 in connection with our operating model modification and the annual impairment test for each of our reporting units as of November 30. We did not identify any impairments during our interim or annual impairment tests performed during 2022. See Note 4 “Goodwill and Intangible Assets” for additional information on our 2024 and 2023 annual goodwill impairment tests. Business Combinations We use the acquisition method of accounting for business combinations . Each acquired company’s operating results are included in our consolidated financial statements starting on the date of acquisition. The purchase price is equivalent to the fair value of consideration transferred. The contract assets and contract liabilities acquired are recorded at their carrying value under Topic 606: Revenue from Contracts with Customers . All other tangible assets and identifiable intangible assets acquired and liabilities assumed are recorded at fair value as of the acquisition date. Goodwill is recognized for the excess of purchase price over the net value of tangible and intangible assets acquired and liabilities assumed. Contingent consideration, which is primarily based on the business achieving certain performance targets, is recognized at its fair value on the acquisition date, and changes in fair value are recognized in earnings until settled. Refer to Note 3 “Acquisitions and Divestiture” for additional information on our business acquisitions and refer to Note 13 “Fair Value of Financial Instruments” for additional information regarding our contingent acquisition liability balances. Income Taxes Current tax liabilities and assets are recognized for the estimated taxes payable or refundable, respectively, on the tax returns for the current year. We have elected to recognize the tax expense related to Global Intangible Low-Taxed Income (“GILTI”) as a current period expense when incurred. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. To the extent that deferred tax assets will not likely be recovered from future taxable income, a valuation allowance is established against such deferred tax assets. Refer to Note 17 “Income Taxes” for further information regarding incomes taxes. Share-Based Compensation Share-based compensation cost is measured based on the grant date fair value of the respective awards. We generally recognize share-based compensation ratably using the straight-line attribution method; however, for those awards with performance criteria and graded vesting features, we use the graded vesting attribution method. It is our policy to account for forfeitures as they occur. Refer to Note 16 “Equity Incentive Plan” for further information regarding share-based compensation. Sponsorship and Advertising Costs Sponsorship and advertising costs are expensed as incurred. Such expenses for the years ended December 31, 2024, 2023, and 2022 totaled $10.2 million, $7.3 million, and $6.3 million, respectively, and are a component of selling, general and administrative expenses on our consolidated statement of operations. Debt Issuance Costs We amortize the costs we incur to obtain debt financing over the contractual life of the related debt using the effective interest method for non-revolving debt and the straight-line method for revolving debt. The amortization expense is included in interest expense, net of interest income in our statement of operations. Unamortized debt issuance costs attributable to our senior secured term loan facility (the “Term Loan”) are included as a discount to the Term Loan. Unamortized debt issuance costs attributable to our senior secured revolving credit facility are included as a component of other non-current assets. Foreign Currency Assets and liabilities of foreign subsidiaries whose functional currency is not the United States Dollar (USD) are translated into USD using the exchange rates in effect at period end. Revenue and expense items are translated using the average exchange rates for the period. Foreign currency translation adjustments are included in accumulated other comprehensive income, which is a component of stockholders’ equity. Foreign currency transaction gains and losses are included in other income (expense), net on the consolidated statement of operations. We recognized $2.1 million of foreign currency transaction gains in 2024, $0.5 million of foreign currency transaction losses in 2023, and $0.7 million of foreign currency transaction gains in 2022. Segment Reporting Segments are defined as components of a company that engage in business activities from which they may earn revenues and incur expenses, and for which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. As of December 31, 2024, our chief operating decision maker manages the business under three operating segments, which are our reportable segments: Healthcare, Education, and Commercial. See Note 19 “Segment Information” for additional information on our reportable segments. New Accounting Pronouncements Recently Adopted On November 27, 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which updates the segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an interim and annual basis. We adopted ASU 2023-07 in the fourth quarter of 2024 on a retrospective basis, resulting in additional disclosures with no impact on our consolidated financial statements. See Note 19 “Segment Information” for the additional disclosures made related to our reportable segments. Not Yet Adopted On December 14, 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures , which updates annual income tax disclosures by requiring disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 will be effective for our annual reporting periods beginning with the fiscal year ending December 31, 2025, with early adoption permitted, and is required to be applied prospectively with the option of retrospective application. We expect the adoption of this ASU will have no impact on our financial position or our results of operations, but will result in additional disclosures. On March 6, 2024, the U.S. Securities and Exchange Commission (“SEC”) adopted the final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors , which will require registrants to disclose certain climate-related information in registration statements and annual reports. The disclosure requirements will be effective for our annual reporting periods beginning with the fiscal year ending December 31, 2025, subject to any delay which may result from the current administrative stay issued by the SEC. We expe

Summary of Significant Accoun_2

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	The consolidated financial statements include the accounts of Huron Consulting Group Inc. and its subsidiaries, all of which are wholly-owned. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts that are reported in the consolidated financial statements and accompanying disclosures. Actual results may differ from these estimates and assumptions.
Revenue Recognition	Revenue Recognition We generate substantially all of our revenues from providing professional services to our clients. We also generate revenues from software licenses; software support and maintenance and subscriptions to our cloud-based analytic tools and solutions; speaking engagements; conferences; and publications. A single contract could include one or multiple performance obligations. For those contracts that have multiple performance obligations, we allocate the total transaction price to each performance obligation based on its relative standalone selling price, which is determined based on our overall pricing objectives, taking into consideration market conditions and other factors. Revenue is recognized when control of the goods and services provided are transferred to our customers and in an amount that reflects the consideration we expect to be entitled to in exchange for those goods and services using the following steps: 1) identify the contract, 2) identify the performance obligations, 3) determine the transaction price, 4) allocate the transaction price to the performance obligations in the contract, and 5) recognize revenue as or when we satisfy the performance obligations. We generate our revenues under four types of billing arrangements: fixed-fee (including software license revenue); time-and-expense; performance-based; and software support, maintenance and subscriptions. • Fixed-fee (including software license revenue): In fixed-fee billing arrangements, we agree to a pre-established fee in exchange for a predetermined set of professional services. We set the fees based on our estimates of the costs and timing for completing the engagements. We generally recognize revenues under fixed-fee billing arrangements using a proportionate performance approach, which is based on work completed to date versus our estimates of the total services to be provided under the engagement. Contracts within our culture and organizational excellence solution include fixed-fee partner contracts with multiple performance obligations, which primarily consist of coaching services, as well as speaking engagements, conferences, publications and software products (“Partner Contracts”). Revenues for coaching services and software products are generally recognized on a straight-line basis over the length of the contract. All other revenues under Partner Contracts, including speaking engagements, conferences and publications, are recognized at the time the goods or services are provided. Estimates of total engagement revenues and cost of services are monitored regularly during the term of the engagement. We also generate revenues from software licenses for our research administration and compliance software, which is generally recognized in the month in which the software is delivered. • Time-and-expense: Under time-and-expense billing arrangements, we invoice our clients based on the number of hours worked by our revenue-generating professionals at agreed upon rates. Time-and-expense arrangements also include certain speaking engagements, conferences, and publications purchased by our clients outside of Partner Contracts within our culture and organizational excellence solution and the portion of our Healthcare managed services contracts that are billed under time-and-expense arrangements. We recognize revenues under time-and-expense arrangements as the related services or publications are provided, using the right to invoice practical expedient which allows us to recognize revenue in the amount that we have a right to invoice based on the number of hours worked and the agreed upon hourly rates or the value of the speaking engagements, conferences or publications purchased by our clients. • Performance-based: In performance-based billing arrangements, fees are tied to the attainment of contractually defined objectives. We enter into performance-based engagements in essentially two forms. First, we generally earn fees that are directly related to the savings formally acknowledged by the client as a result of adopting our recommendations for improving operational and cost effectiveness in the areas we review. Second, we earn a success fee when and if certain predefined outcomes occur. We recognize revenue under performance-based billing arrangements using the following steps: 1) estimate variable consideration using either the expected value method or the most likely amount method, as appropriate 2) apply a constraint to the estimated variable consideration to limit the amount that could be reversed when the uncertainty is resolved (the “constraint”), and 3) recognize revenue of estimated variable consideration, net of the constraint, based on work completed to date versus our estimates of the total services to be provided under the engagement. • Software support, maintenance and subscriptions: Clients that have purchased one of our software licenses can pay an annual fee for software support and maintenance. We also generate subscription revenue from our cloud-based analytic tools and solutions including our cloud-based revenue cycle management software and research administration and compliance software. Software support, maintenance and subscription revenues are recognized ratably over the support or subscription period. These fees are generally billed in advance and included in deferred revenues until recognized. Provisions are recorded for the estimated realization adjustments on all engagements, including engagements for which fees are subject to review by the bankruptcy courts. Reimbursable expenses that are billed to clients, primarily relating to travel and out-of-pocket expenses incurred in connection with client engagements, are included in total revenues and reimbursable expenses. Reimbursable expenses are recognized as expenses in the period in which the expense is incurred.
Commissions Expense, Policy [Policy Text Block]	Capitalized Sales Commissions
Allowances for Doubtful Accounts and Unbilled Services	Allowances for Doubtful Accounts and Unbilled Services We maintain allowances for doubtful accounts and unbilled services based on several factors, including the estimated cash realization from amounts due from clients, an assessment of a client’s ability to make required payments, and the historical percentages of fee adjustments and write-offs by age of receivables and unbilled services. The allowances are assessed by management on a regular basis. These estimates may differ from actual results. If the financial condition of a client deteriorates in the future, impacting the client’s ability to make payments, an increase to our allowance might be required or our allowance may not be sufficient to cover actual write-offs. We record the provision for doubtful accounts and unbilled services as a reduction in revenue. To the extent we write-off accounts receivable due to a client's inability to pay, the charge is recognized as a component of selling, general and administrative expenses.
Direct Costs and Reimbursable Expenses	Direct Costs Direct costs primarily consist of payroll costs for our revenue-generating professionals which includes salaries, performance bonuses, share-based compensation, signing and retention bonuses, payroll taxes and benefits. Direct costs also include fees paid to independent contractors that we retain to supplement our revenue-generating professionals, typically on an as-needed basis for specific client engagements, as well as technology costs, product and event costs, and commissions. Direct costs exclude reimbursable expenses and amortization of intangible assets and software development costs, both of which are separately presented in our consolidated statements of operations. Direct costs are expensed in the period incurred.
Cash and Cash Equivalents	Cash and Cash Equivalents We consider all highly liquid investments, including overnight investments and commercial paper, with original maturities of three months or less to be cash equivalents.
Concentrations of Credit Risk	Concentrations of Credit Risk To the extent receivables from clients become delinquent, collection activities commence. No single client balance is considered large enough to pose a material credit risk. The allowances for doubtful accounts and unbilled services are based upon the expected ability to collect accounts receivable and bill and collect unbilled services. Management does not anticipate incurring losses on accounts receivable in excess of established allowances. See Note 19 “Segment Information” for concentration of accounts receivable and unbilled services. We hold our cash in accounts at multiple third-party financial institutions. These deposits, at times, may exceed federally insured limits. We review the credit ratings of these financial institutions, regularly monitor the cash balances in these accounts, and adjust the balances as appropriate. However, these cash balances could be impacted if the underlying financial institutions fail or are subject to other adverse conditions in the financial markets.
Investments	Long-term Investments Our long-term investments consist of our convertible debt investment in Shorelight Holdings, LLC (“Shorelight”) and preferred stock investment in a hospital-at-home company. We classified the convertible debt investment in Shorelight as available-for-sale at the time of purchase and reevaluate such classification as of each balance sheet date. The investment is carried at fair value with unrealized holding gains and losses reported in other comprehensive income. If the investment is in an unrealized loss position due to significant credit deterioration of the investee, we recognize an allowance to decrease the carrying value of the investment to the fair value, which may be reversed in the event that the credit of an issuer improves. In the event there are realized gains and losses or credit allowances recognized, we will record the amount in earnings. We have not realized any gains or losses or recognized any credit allowance on our convertible debt investment as of December 31, 2024. See Note 13 “Fair Value of Financial Instruments” for additional information on our convertible debt investment.
Property and Equipment	Property and Equipment Property and equipment is recorded at cost, less accumulated depreciation, and depreciated using the straight-line method over the shorter of the estimated useful life of the asset or the lease term. Software, computers, and related equipment are depreciated over a useful life of two
Deferred Lease Incentives	Leases We determine if an arrangement contains a lease and the classification of such lease at inception. As of December 31, 2024 and 2023, all of our material leases are classified as operating leases; we have not entered into any material finance leases. For all operating leases with an initial term greater than 12 months, we recognize an operating lease right-of-use (“ROU”) asset and operating lease liability. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. Operating lease ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the lease commencement date and provided by the administrative agent for our senior secured credit facility in determining the present value of lease payments. Operating lease ROU assets exclude lease incentives. We elected the practical expedient to combine lease and nonlease components. Certain lease agreements contain variable lease payments that do not depend on an index or rate. These variable lease payments are not included in the calculation of the operating lease ROU asset and operating lease liability; instead, they are expensed as incurred. Our leases may contain options to extend or terminate the lease, and we include these terms in our calculation of the operating lease ROU asset and operating lease liability when it is reasonably certain that we will exercise the option.
Software Development Costs	Software Development Costs We capitalize internal and external software development costs related to our cloud computing applications and software for internal use, which we account for in accordance with ASC 350-40: Intangibles - Goodwill and Other, Internal-Use Software; and related to software products that will be sold, leased, or marketed, which we account for in accordance with ASC 985: Software-Costs of Software to be Sold, Leased, or Marketed. These capitalized costs are included as a component of other non-current assets on our consolidated balance sheet and the related amortization is recorded to depreciation and amortization on our consolidated statements of operations. Under ASC 350-40, we capitalize software development costs incurred during the application development stage. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Once the project is substantially complete and ready for its intended use, these costs are amortized on a straight-line basis over the technology's estimated useful life. Acquired technology assets are initially recorded at fair value and amortized on a straight-line basis over the estimated useful life. As of December 31, 2024, gross capitalized internal-use software development costs and related accumulated amortization was $94.3 million and $33.8 million, respectively. As of December 31, 2023, gross capitalized internal-use software development costs and related accumulated amortization was $72.3 million and $26.8 million, respectively. During the years ended December 31, 2024, 2023, and 2022, we amortized $7.6 million, $6.5 million, and $5.9 million, respectively, of such software development costs. Under ASC 985, software development costs are expensed until technological feasibility has been established. Thereafter, and until the software is available for general release to customers, these software development costs are capitalized and subsequently reported at the lower of unamortized cost or net realizable value. These capitalized development costs are amortized in proportion to current and future revenue for each product with an annual minimum equal to the straight-line amortization over the remaining estimated economic life of the product. As of December 31, 2024, gross capitalized software development costs related to software products that will be sold, leased or otherwise marketed and related accumulated amortization was $0.7 million and $0.1 million, respectively. During the year ended December 31, 2024, we amortized $0.1 million of such capitalized costs. We did not capitalize any material development costs for this type of software during 2023. Implementation Costs Incurred in a Cloud Computing Arrangement
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]	Intangible Assets Other Than Goodwill Identifiable intangible assets are amortized over their expected useful lives using a method that reflects the economic benefit expected to be derived from the assets or on a straight-line basis. We evaluate the recoverability of intangible assets periodically by considering events or circumstances that may warrant revised estimates of useful lives or that indicate the asset may be impaired.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets
Goodwill	Goodwill
Business Combinations	Business Combinations We use the acquisition method of accounting for business combinations . Each acquired company’s operating results are included in our consolidated financial statements starting on the date of acquisition. The purchase price is equivalent to the fair value of consideration transferred. The contract assets and contract liabilities acquired are recorded at their carrying value under Topic 606: Revenue from Contracts with Customers
Income Taxes	Income Taxes
Share-Based Compensation	Share-Based Compensation Share-based compensation cost is measured based on the grant date fair value of the respective awards. We generally recognize share-based compensation ratably using the straight-line attribution method; however, for those awards with performance criteria and graded vesting features, we use the graded vesting attribution method. It is our policy to account for forfeitures as they occur. Refer to Note 16 “Equity Incentive Plan” for further information regarding share-based compensation.
Sponsorship and Advertising Costs	Sponsorship and Advertising Costs
Debt Issuance Costs	Debt Issuance Costs
Foreign Currency	Foreign Currency Assets and liabilities of foreign subsidiaries whose functional currency is not the United States Dollar (USD) are translated into USD using the exchange rates in effect at period end. Revenue and expense items are translated using the average exchange rates for the period. Foreign currency translation adjustments are included in accumulated other comprehensive income, which is a component of stockholders’ equity.
Segment Reporting	Segment Reporting Segments are defined as components of a company that engage in business activities from which they may earn revenues and incur expenses, and for which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. As of December 31, 2024, our chief operating
New Accounting Pronouncements	New Accounting Pronouncements Recently Adopted On November 27, 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which updates the segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an interim and annual basis. We adopted ASU 2023-07 in the fourth quarter of 2024 on a retrospective basis, resulting in additional disclosures with no impact on our consolidated financial statements. See Note 19 “Segment Information” for the additional disclosures made related to our reportable segments. Not Yet Adopted On December 14, 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures , which updates annual income tax disclosures by requiring disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 will be effective for our annual reporting periods beginning with the fiscal year ending December 31, 2025, with early adoption permitted, and is required to be applied prospectively with the option of retrospective application. We expect the adoption of this ASU will have no impact on our financial position or our results of operations, but will result in additional disclosures. On March 6, 2024, the U.S. Securities and Exchange Commission (“SEC”) adopted the final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors , which will require registrants to disclose certain climate-related information in registration statements and annual reports. The disclosure requirements will be effective for our annual reporting periods beginning with the fiscal year ending December 31, 2025, subject to any delay which may result from the current administrative stay issued by the SEC. We expect the adoption will have no impact on our financial position or our results of operations, but we are currently evaluating the impact this guidance will have on our disclosures within our consolidated financial statements. On November 4, 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expense s, which is intended to enhance transparency of the nature and function of expenses, primarily through additional disclosures of certain cost and expenses. ASU 2024-03 will be effective for our annual reporting periods beginning with the fiscal year ending December 31, 2027 and for interim reporting periods beginning in fiscal year 2028, with early adoption permitted, and is required to be applied prospectively with the option of retrospective application. We expect the adoption of this ASU will have no impact on our financial position or our results of operations, but will result in additional disclosures.

Description of Business

Description of Business	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Description of Business	Description of Business Huron is a global professional services firm that partners with clients to put possible into practice by creating sound strategies, optimizing operations, accelerating digital transformation, and empowering businesses to own their future. By embracing diverse perspectives, encouraging new ideas and challenging the status quo, we create sustainable results for the organizations we serve. We provide our services and products and manage our business under three operating segments - Healthcare, Education, and Commercial - which aligns our business by industry. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services, energy and utilities, industrials and manufacturing, and the public sector. We also provide revenue reporting across two principal capabilities: i) Consulting and Managed Services and ii) Digital, which are methods by which we deliver our services and products.

Acquisitions & Divestitures

Acquisitions & Divestitures	12 Months Ended
	Dec. 31, 2024
Business Combinations [Abstract]
Acquisitions	Acquisitions and Divestiture Acquisitions 2024 Vlamis Software Solutions, Inc. On January 1, 2024, we completed the acquisition of the data analytics services team of Vlamis Software Solutions, Inc. (“Vlamis”). The results of operations of Vlamis are included within our consolidated financial statements as of the acquisition date and allocated among our Education and Commercial segments based on the engagements delivered by the business. Grenzebach Glier and Associates, Inc. On March 1, 2024, we completed the acquisition of Grenzebach Glier and Associates, Inc. (“GG+A”), a philanthropic management consulting firm that helps education institutions and other nonprofit organizations build and accelerate the philanthropic programs, in order to expand our philanthropic consulting offerings. The results of operations of GG+A are included within our consolidated financial statements and results of operations of our Education segment as of the acquisition date. AXIA Consulting, Inc. On December 2, 2024, we completed the acquisition of AXIA Consulting, Inc. (“AXIA Consulting”), a provider of supply chain-focused consulting and technology solutions, in order to expand our supply chain consulting and Oracle supply chain management (SCM) offerings and broaden our Microsoft capabilities. The results of operations of AXIA Consulting are included within our consolidated financial statements and allocated among our three operating segments based on the engagements delivered by the business. The acquisitions of Vlamis, GG+A, and AXIA Consulting are not significant to our consolidated financial statements individually or in the aggregate as of and for the year ended December 31, 2024. The current acquisition date values of assets acquired and liabilities assumed from the AXIA Consulting acquisition are considered preliminary and are based on the information that was available as of the date of the acquisition. We believe that the information provides a reasonable basis for estimating the preliminary values of assets acquired and liabilities assumed but certain items, such as the intangible assets valuations and the working capital adjustments, among other things, may be subject to change as additional information is received. Thus, the provisional measurements of assets acquired, including goodwill, and liabilities assumed related to the AXIA Consulting acquisition are subject to change. We expect to finalize the valuation as soon as practicable, but not later than one year from the acquisition date. 2023 Roundtable Analytics, Inc. On September 1, 2023, we completed the acquisition of Roundtable Analytics, Inc. (“Roundtable”), a healthcare analytics company. The results of operations of Roundtable are included within our consolidated financial statements and results of operations of our Healthcare segment from the date of the acquisition. The acquisition of Roundtable was not significant to our consolidated financial statements as of and for the year ended December 31, 2023. 2022 AIMDATA, LLC On January 18, 2022, we completed the acquisition of AIMDATA, LLC (“AIMDATA”), an advisory and implementation consulting services firm focused on strategy, technology and business transformation. The results of operations of AIMDATA are included within our consolidated financial statements as of the acquisition date and allocated among our three operating segments, based on the engagements delivered by the business. Customer Evolution, LLC Effective December 31, 2022, we completed the acquisition of Customer Evolution, LLC (“Customer Evolution”), a healthcare advisory and technology implementation consulting services firm. The results of operations of Customer Evolution are included in our consolidated financial statements and results of operations of our Healthcare segment beginning January 1, 2023. The acquisitions of AIMDATA and Customer Evolution were not significant to our consolidated financial statements individually or in the aggregate as of and for the year ended December 31, 2022. Divestiture 2024 Studer Education

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The table below sets forth the changes in the carrying amount of goodwill by reportable segment for the years ended December 31, 2024 and 2023. Healthcare Education Commercial Total Balance as of December 31, 2022: Goodwill $ 644,238 $ 123,652 $ 312,968 $ 1,080,858 Accumulated impairment losses (190,024) (1,417) (264,451) (455,892) Goodwill, net as of December 31, 2022 $ 454,214 $ 122,235 $ 48,517 $ 624,966 Goodwill recorded in connection with a business combination (1) 745 — — 745 Balance as of December 31, 2023: Goodwill $ 644,983 $ 123,652 $ 312,968 $ 1,081,603 Accumulated impairment losses (190,024) (1,417) (264,451) (455,892) Goodwill, net as of December 31, 2023 $ 454,959 $ 122,235 $ 48,517 $ 625,711 Goodwill recorded in connection with business combinations (1) 869 22,476 32,134 55,479 Goodwill allocated to disposal of business (2) (2,300) — — (2,300) Foreign currency translation — (147) — (147) Balance as of December 31, 2024: Goodwill $ 643,552 $ 145,981 $ 345,102 $ 1,134,635 Accumulated impairment losses (190,024) (1,417) (264,451) (455,892) Goodwill, net as of December 31, 2024: $ 453,528 $ 144,564 $ 80,651 $ 678,743 (1) See Note 3 “Acquisitions and Divestiture” for additional information on business combinations completed in 2024, 2023 and 2022. (2) In 2024, we completed the divestiture of our Studer Education practice within our Healthcare segment, and allocated a portion of goodwill within the Healthcare segment to the disposed practice based on the relative fair values of Studer Education and the remaining segment. The allocated goodwill of $2.3 million was written off and included in the gain on sale of Studer Education. The sale of Studer Education did not meet the criteria for reporting separately as discontinued operations. In connection with the sale, we recorded a $3.6 million pretax gain which is included in other income (expense), net in our consolidated statements of operations. 2024 Annual Goodwill Impairment Test Pursuant to our policy, we performed our annual goodwill impairment test as of November 30, 2024 for our three reporting units: Healthcare, Education, and Commercial. We elected to bypass the qualitative assessment and utilized a quantitative goodwill impairment test to provide an updated fair value for each reporting unit as of the most recent valuation quantitative analysis performed was as of January 1, 2022. We reviewed goodwill for impairment by comparing the fair value of the reporting unit to its carrying value, including goodwill. In estimating the fair value of the reporting unit, we relied on a combination of the income approach and the market approach utilizing the guideline company method, with a fifty-fifty weighting. Based on the results of the goodwill impairment test, we determined the fair value of the Healthcare, Education, and Commercial reporting units exceeded their carrying value by approximately 105%, 185%, and 335%, respectively. As such, we concluded that there is no indication of goodwill impairment for these three reporting units. In the income approach, we utilized a discounted cash flow analysis, which involved estimating the expected after-tax cash flows that will be generated by each reporting unit and then discounting those cash flows to present value, reflecting the relevant risks associated with each reporting unit and the time value of money. This approach requires the use of significant estimates and assumptions, including forecasted revenue growth rates, forecasted EBITDA margins, and discount rates that reflect the risk inherent in the future cash flows. In estimating future cash flows, we relied on internally generated ten-year forecasts. Our forecasts are based on historical experience, current backlog, expected market demand, and other industry information. In the market approach, we utilized the guideline company method, which involved calculating EBITDA multiples based on operating data from guideline publicly traded companies. Multiples derived from guideline companies provide an indication of how much a knowledgeable investor in the marketplace would be willing to pay for a company. These multiples were evaluated and adjusted based on specific characteristics of each of the reporting units relative to the selected guideline companies and applied to the reporting units' operating data to arrive at an indication of value. Further, we evaluated whether any events have occurred or any circumstances have changed since November 30, 2024 that would indicate goodwill may have become impaired since our annual impairment test. Based on our evaluation as of December 31, 2024, we determined that no indications of impairment have arisen since our annual goodwill impairment test. The results of an impairment analysis are as of a point in time. There is no assurance that the actual future earnings or cash flows of our reporting units will be consistent with our projections. We will monitor any changes to our assumptions and will evaluate goodwill as deemed warranted during future periods. Any significant decline in our operations could result in non-cash goodwill impairment charges. 2023 Annual Goodwill Impairment Test Pursuant to our policy, we performed our annual goodwill impairment test as of November 30, 2023 for our three reporting units: Healthcare, Education, and Commercial. We performed a qualitative assessment considering the most recent quantitative analysis performed, actual performance, our internal financial projections, and current carrying value of each reporting unit; as well as other various factors, including macroeconomic conditions, relevant industry and market trends for each reporting unit, and other entity-specific events. Based on our evaluation as of November 30, 2023, we determined that there were no indications of goodwill impairment for any of our reporting units. Intangible Assets Intangible assets as of December 31, 2024 and 2023 consisted of the following: As of December 31, 2024 2023 Useful Life Gross Accumulated Gross Accumulated Customer relationships 5 to 10 $ 30,683 $ 9,790 $ 60,636 $ 48,928 Technology and software 2 to 5 16,230 12,771 16,230 10,195 Trade names 6 6,000 6,000 6,000 6,000 Customer contracts 2 to 4 1,483 418 — — Non-competition agreements 2 to 5 1,260 601 720 389 Total $ 55,656 $ 29,580 $ 83,586 $ 65,512 We acquired intangible assets related to our acquisitions of $14.6 million and $2.9 million during the years ended December 31, 2024 and 2023, respectively. These acquired intangible assets consist of customer relationships, technology and software, customer contracts and non-competition agreements. See Note 3 “Acquisitions and Divestiture” for additional information on the business acquisitions completed in 2024 and 2023. During the years ended December 31, 2024 and 2023, we wrote-off $42.4 million and $14.1 million, respectively, of fully amortized intangible assets no longer in use; which primarily consisted of customer relationships. Identifiable intangible assets with finite lives are amortized over their estimated useful lives using either an accelerated or straight-line basis to correspond to the cash flows expected to be derived from the assets. Intangible assets amortization expense was $6.5 million, $8.2 million, and $11.2 million for the years ended December 31, 2024, 2023, and 2022, respectively. The table below sets forth the estimated annual amortization expense for each of the five succeeding years for the intangible assets recorded as of December 31, 2024. Year Ending December 31, Estimated 2025 $ 7,632 2026 $ 5,882 2027 $ 4,480 2028 $ 3,606 2029 $ 2,477

Leases Leases

Leases Leases	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Lessee, Operating Leases	Leases We lease office space, data centers and certain equipment under operating leases expiring on various dates through 2030, with various renewal options that can extend the lease terms by one Lease Impairment Charges Operating lease right-of-use (“ROU”) assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset group to which the operating lease ROU asset is assigned may not be recoverable. First, we test the asset group for recoverability by comparing the undiscounted cash flows of the asset group, which include expected future lease and nonlease payments related to the lease agreement offset by expected sublease income, to the carrying amount of the asset group. If the first step of the long-lived asset impairment test concludes that the carrying amount of the asset group is not recoverable, we perform the second step of the long-lived asset impairment test by comparing the fair value of the asset group to its carrying amount and recognizing a lease impairment charge for the amount by which the carrying amount exceeds the fair value. To estimate the fair value of the asset group, we rely on a discounted cash flow approach using market participant assumptions of the expected cash flows and discount rate. During the years ended December 31, 2024, 2023, and 2022 we recognized non-cash lease-related impairment charges of $3.5 million, $6.3 million, and $0.2 million, respectively. 2024 During 2024, we exited our office space previously occupied by GG+A and a portion of our office space in New York, New York, resulting in non-cash impairment charges of $2.7 million, of which $2.0 million was allocated to the operating lease ROU assets and $0.7 million was allocated to the related fixed assets based on their relative carrying amounts. Additionally, in 2024, we recognized $0.8 million of lease-related impairment charges driven by updated sublease assumptions for our previously vacated office spaces in Lexington, Massachusetts; and Lake Oswego, Oregon. Of the $0.8 million, $0.7 million was allocated to the fixed assets related to the office spaces and $0.1 million was allocated to the operating lease ROU assets based on their relative carrying amounts. 2023 During 2023, we exited our office spaces in Hillsboro, Oregon and Lexington, Massachusetts, resulting in non-cash impairment charges of $5.4 million, of which $4.0 million was allocated to the operating lease ROU assets and $1.4 million was allocated to the related fixed assets based on their relative carrying amounts. Additionally, in 2023, we recognized $0.9 million of lease-related impairment charges driven by updated sublease assumptions for our previously vacated office spaces in Hillsboro, Oregon; New York, New York; and Lake Oswego, Oregon. Of the $0.9 million, $0.5 million was allocated to the fixed assets related to the office spaces and $0.4 million was allocated to the operating lease ROU assets based on their relative carrying amounts. 2022 The $0.2 million lease-related impairment charge recognized in 2022 resulted from updated sublease assumptions for our previously vacated office space in New York, New York and was allocated to the operating lease ROU asset. See Note 11 “Restructuring Charges” for additional information on our restructuring activities. Additional information on our operating leases as of December 31, 2024 and 2023 follows. As of December 31, Balance Sheet 2024 2023 Operating lease right-of-use assets $ 19,176 $ 24,131 Current maturities of operating lease liabilities $ 12,315 $ 11,032 Operating lease liabilities, net of current portion 29,686 38,850 Total lease liabilities $ 42,001 $ 49,882 Year Ended December 31, Lease Cost 2024 2023 2022 Operating lease cost $ 7,939 $ 8,514 $ 8,877 Short-term lease cost (1) 565 608 263 Variable lease costs 4,935 3,908 4,587 Sublease income (2,446) (2,157) (1,921) Net lease cost (2) $ 10,993 $ 10,873 $ 11,806 (1) Includes variable lease costs related to short-term leases. (2) Net lease cost includes $2.2 million, $1.8 million and $2.0 million for the years ended December 31, 2024, 2023 and 2022, respectively, recorded as restructuring charges as they relate to vacated office spaces. See Note 11 “Restructuring Charges” for additional information on our vacated office spaces. The table below summarizes the remaining expected lease payments under our operating leases as of December 31, 2024. Future Lease Payments December 31, 2025 $ 14,139 2026 12,920 2027 9,465 2028 5,907 2029 3,624 Thereafter 426 Total operating lease payments $ 46,481 Less: imputed interest (4,480) Present value of operating lease liabilities $ 42,001 Year Ended December 31, Other Information 2024 2023 2022 Cash paid for operating lease liabilities $ 13,458 $ 13,107 $ 12,634 Operating lease right-of-use assets obtained in exchange for operating lease liabilities $ 4,286 $ 4,678 $ 1,908 Weighted average remaining lease term - operating leases 3.7 years 4.5 years 5.3 years Weighted average discount rate - operating leases 4.3 % 4.4 % 4.2 %

Property and Equipment, Net

Property and Equipment, Net	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Depreciation expense for property and equipment was $10.6 million, $10.2 million, and $10.3 million for the years ended December 31, 2024, 2023 and 2022, respectively. Additionally, during the years ended December 31, 2024 and 2023, we recognized $0.5 million and less than $0.1 million of accelerated depreciation expense for fixed assets related to vacated office spaces. There was no accelerated depreciation expense for fixed assets related to vacated office spaces during 2022. This accelerated depreciation expense is included as a component of restructuring charges. See Note 11 “Restructuring Charges” for additional information on our restructuring charges incurred in 2024, 2023 and 2022. Property and equipment, net at December 31, 2024 and 2023 consisted of the following: As of December 31, 2024 2023 Computers, related equipment, and software $ 32,383 $ 40,174 Leasehold improvements 32,254 33,290 Furniture and fixtures 8,665 10,066 Assets under construction 1,617 866 Property and equipment 74,919 84,396 Accumulated depreciation (53,241) (60,668) Property and equipment, net $ 21,678 $ 23,728

Financing Arrangements

Financing Arrangements	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Financing Arrangements	Financing Arrangements The Company has a $600 million senior secured revolving credit facility (the “Revolver”) and a $275 million senior secured term loan facility (the “Term Loan”), subject to the terms of the Third Amended and Restated Credit Agreement dated as of November 15, 2022 (as amended, the “Amended Credit Agreement”), both of which fully mature on November 15, 2027. The Term Loan was established in February 2024 with the execution of Amendment No. 2 to the Third Amended and Restated Credit Agreement. The Term Loan is subject to scheduled quarterly amortization payments of $3.4 million which began June 30, 2024 and continue through the maturity date of November 15, 2027, at which time the outstanding principal balance and all accrued interest will be due. As of December 31, 2024, we had total borrowings outstanding under our Amended Credit Agreement of $357.7 million, consisting of $93.0 million outstanding under the Revolver and $264.7 million outstanding under the Term Loan. A summary of the scheduled maturities of those borrowings follows: Scheduled Maturities of Long-Term Debt 2025 $ 13,750 2026 $ 13,750 2027 $ 330,187 The initial borrowings under the Revolver were used to refinance borrowings outstanding under a prior credit agreement, and future borrowings under the Revolver may be used for working capital, capital expenditures, share repurchases, permitted acquisitions, and other general corporate purposes. The proceeds of the Term Loan were used to reduce borrowings under the Revolver. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish additional term loan facilities in an aggregate amount up to $250 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $1.13 billion. Fees and interest on borrowings under the Amended Credit Agreement vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, these borrowings will bear interest at one, three or six month Term SOFR or, in the case of the Revolver, an alternate base rate, in each case plus the applicable margin. The applicable margin for borrowings under the Revolver will fluctuate between 1.125% per annum and 1.875% per annum, in the case of Term SOFR borrowings, or between 0.125% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time. The applicable margin for the outstanding principal under the Term Loan will range between 1.625% per annum and 2.375% per annum based upon our Consolidated Leverage Ratio at such time. The fees and interest are subject to further adjustment based upon the Company's performance against specified key performance indicators. Based upon the performance of the Company against those key performance indicators in each Reference Year (as defined in the Amended Credit Agreement), certain adjustments to the otherwise applicable rates for interest, commitment fees and letter of credit fees will be made. These annual adjustments will not exceed an increase or decrease of 0.01% in the aggregate for all key performance indicators in the case of the commitment fee rate or an increase or decrease of 0.05% in the aggregate for all key performance indicators in the case of the Term SOFR borrowings, base rate borrowings or letter of credit fee rate. Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including upon an Event of Default (as defined in the Amended Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time. The loans and obligations under the Amended Credit Agreement are secured pursuant to a Third Amended and Restated Security Agreement and a Third Amended and Restated Pledge Agreement (the “Pledge Agreement”) with Bank of America, N.A. as collateral agent, pursuant to which the Company and the subsidiary guarantors grant Bank of America, N.A., for the ratable benefit of the lenders under the Amended Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors, and a pledge of 100% of the stock or other equity interests in all domestic subsidiaries and 65% of the stock or other equity interests in each “material first-tier foreign subsidiary” (as defined in the Pledge Agreement) entitled to vote and 100% of the stock or other equity interests in each material first-tier foreign subsidiary not entitled to vote. The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to 4.25 to 1.00 upon the occurrence of a Qualified Acquisition (as defined in the Amended Credit Agreement), and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.00 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. For purposes of the Consolidated Leverage Ratio total debt is on a gross basis and is not netted against our cash balances. At December 31, 2024, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of 1.39 to 1.00 and a Consolidated Interest Coverage Ratio of 10.50 to 1.00. A summary of the carrying amounts of our debt follows: December 31, December 31, Revolver $ 93,000 $ 324,000 Term Loan 264,687 — Unamortized debt issuance costs - Term Loan 1 (1,080) — Total long-term debt 356,607 324,000 Current maturities of long-term debt (13,750) — Long-term debt, net of current portion $ 342,857 $ 324,000 (1) In connection with establishing the Term Loan, we incurred $1.4 million of debt issuance costs which were recognized as a discount to the Term Loan. These debt issuance costs are amortized to interest expense using an effective interest rate of 7.34% over the term of the Term Loan. Unamortized debt issuance costs related to the Revolver are included as a component of other non-current assets and amortized to interest expense using the straight-line method over the term of the Revolver. Borrowings outstanding under the Amended Credit Agreement as of December 31, 2024 and 2023 carried a weighted average interest rate of 4.7% and 4.2%, respectively, including the effect of the interest rate swaps described in Note 12 "Derivative Instruments and Hedging Activity." The borrowing capacity under the Revolver is reduced by any outstanding borrowings under the Revolver and outstanding letters of credit. At December 31, 2024, we had outstanding letters of credit totaling $0.4 million, which are used as security deposits for our office facilities. As of December 31, 2024, the unused borrowing capacity under the Revolver was $506.6 million.

Capital Structure

Capital Structure	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Capital Structure	Capital Structure Preferred Stock We are authorized to issue up to 50,000,000 shares of preferred stock. Our certificate of incorporation authorizes our board of directors, without any further stockholder action or approval, to issue these shares in one or more classes or series, to establish from time to time the number of shares to be included in each class or series, and to fix the rights, preferences and privileges of the shares of each wholly unissued class or series and any of its qualifications, limitations or restrictions. As of December 31, 2024 and 2023, no such preferred stock has been approved or issued. Common Stock We are authorized to issue up to 500,000,000 shares of common stock, par value $.01 per share. The holders of common stock are entitled to one vote for each share held of record on each matter submitted to a vote of stockholders. Subject to the rights and preferences of the holders of any series of preferred stock that may at the time be outstanding, holders of common stock are entitled to such dividends as our board of directors may declare. In the event of any liquidation, dissolution or winding-up of our affairs, after payment of all of our debts and liabilities and subject to the rights and preferences of the holders of any series of preferred stock that may at the time be outstanding, holders of common stock will be entitled to receive the distribution of any of our remaining assets.

Revenues Revenue

Revenues Revenue	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer [Text Block]	. Revenues For the years ended December 31, 2024, 2023 and 2022 we recognized total revenues of $1.52 billion, $1.40 billion, and $1.16 billion, respectively. Of the $1.52 billion total revenues recognized in 2024, we recognized revenues of $26.3 million from obligations satisfied, or partially satisfied, in prior periods, of which $22.8 million was primarily due to changes in the estimates of our variable consideration under performance-based billing arrangements and $3.5 million was primarily due to the release of allowances on receivables from clients and unbilled services. Of the $1.40 billion total revenues recognized in 2023, we recognized revenues of $10.9 million from obligations satisfied, or partially satisfied, in prior periods, of which $9.6 million was primarily due to changes in the estimates of our variable consideration under performance-based billing arrangements and $1.3 million was primarily due to the release of allowances on receivables from clients and unbilled services. Of the $1.16 billion total revenues recognized in 2022, we recognized revenues of $7.6 million from obligations satisfied, or partially satisfied, in prior periods, of which $5.3 million was primarily due to changes in the estimates of our variable consideration under performance-based billing arrangements and $2.3 million was primarily due to the release of allowances on receivables from clients and unbilled services. As of December 31, 2024, we had $187.6 million of remaining performance obligations under engagements with original expected durations greater than one year. These remaining performance obligations exclude variable consideration which has been excluded from the total transaction price due to the constraint and performance obligations under time-and-expense engagements which are recognized in the amount invoiced. Of the $187.6 million of performance obligations, we expect to recognize approximately $80.4 million as revenue in 2025, $56.3 million in 2026, and the remaining $50.9 million thereafter. Actual revenue recognition could differ from these amounts as a result of changes in the estimated timing of work to be performed, adjustments to estimated variable consideration in performance-based arrangements, or other factors. Contract Assets and Liabilities The payment terms and conditions in our customer contracts vary. Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenues in the consolidated balance sheets. Unbilled services include revenues recognized for services performed but not yet billed to clients. Services performed that we are not yet entitled to bill because certain events, such as the completion of the measurement period or client approval in performance-based engagements, must occur are recorded as contract assets and included within unbilled services, net. The contract asset balance, net as of December 31, 2024 and 2023 was $60.1 million and $70.1 million, respectively. The $10.0 million decrease primarily reflects timing differences between the completion of our performance obligations and the amounts billed or billable to clients in accordance with their contractual billing terms. Client prepayments and retainers are classified as deferred revenues and recognized over future periods in accordance with the applicable engagement agreement and our revenue recognition accounting policy. Our deferred revenues balance as of December 31, 2024 and 2023 was $26.9 million and $22.5 million respectively. The $4.4 million increase primarily reflects timing differences between client payments in accordance with their contract terms and the completion of our performance obligations. For the year ended December 31, 2024, $21.9 million of revenues recognized were included in the deferred revenue balance as of December 31, 2023. For the year ended December 31, 2023, $21.3 million of revenues recognized were included in the deferred revenue balance as of December 31, 2022.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, unvested restricted stock units, and outstanding common stock options, to the extent dilutive. In periods for which we report a net loss, diluted weighted average common shares outstanding excludes all potential common stock equivalents as their impact on diluted net loss per share would be anti-dilutive. Earnings per share under the basic and diluted computations are as follows: Year Ended December 31, 2024 2023 2022 Net income $ 116,626 $ 62,479 $ 75,552 Weighted average common shares outstanding—basic 17,894 18,832 20,249 Weighted average common stock equivalents 719 769 497 Weighted average common shares outstanding—diluted 18,613 19,601 20,746 Net income per basic share $ 6.52 $ 3.32 $ 3.73 Net income per diluted share $ 6.27 $ 3.19 $ 3.64 The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above at December 31, 2024, 2023 and 2022 was less than 0.1 million, 0.1 million and 0.2 million, respectively, and related to unvested restricted stock and outstanding common stock options. Share Repurchase Program In November 2020, our board of directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021. The share repurchase program has been subsequently extended and increased, most recently in the second quarter of 2024. The current authorization extends the share repurchase program through December 31, 2025 with a repurchase amount of $500 million. The amount and timing of repurchases under the share repurchase program were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. During 2024, we repurchased and retired 1,218,434 shares for $122.2 million, which includes a $0.5 million accrual for excise taxes on the net share repurchases in 2024 and includes 5,103 shares for $0.6 million which were settled in the first quarter of 2025. Additionally, in 2024, we settled the repurchase of 10,000 shares for $1.0 million which were accrued as of December 31, 2023 and we paid $0.9 million for the excise taxes accrued on the net share repurchases in 2023. During 2023, we repurchased and retired 1,461,815 shares for $123.6 million, which includes a $0.9 million accrual for excise taxes on the net share repurchases in 2023 and includes 10,000 shares for $1.0 million which were settled in the first quarter of 2024. Additionally, in the first quarter of 2023, we settled the repurchase of 15,200 shares for $1.1 million which were accrued as of December 31, 2022. During 2022, we repurchased and retired 2,037,752 shares for $121.3 million, which includes 15,200 shares for $1.1 million which were settled in the first quarter of 2023. Additionally, in the first quarter of 2022, we settled the repurchase of 3,820 shares for $0.2 million which were accrued as of December 31, 2021.

Restructuring Charges

Restructuring Charges	12 Months Ended
	Dec. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring Charges	Restructuring Charges 2024 In 2024, we incurred $9.9 million of restructuring charges, of which $1.3 million related to the divestiture of our Studer Education practice. On December 31, 2024, we completed the divestiture of our Studer Education practice and recognized a $3.6 million pretax gain which is included within other income (expense), net on our consolidated statement of operations. The total restructuring charge of $9.9 million recognized in 2024 consisted of the following: Employee costs - We incurred $3.3 million of severance-related restructuring expense, of which $2.3 million related to strategic workforce adjustments to better align our resources with market demand and $1.0 million related to transaction-related employee payments made in connection with the divestiture of our Studer Education practice. Office space reductions - We incurred $6.2 million of restructuring expense related to office space reductions. During 2024, we exited our office space previously occupied by GG+A and a portion of our office space in New York, New York resulting in non-cash impairment charges of $1.4 million and $1.2 million, respectively, on the related right-of-use operating lease assets and fixed assets. Additionally, we exited the remaining portion of our office space in Denver, Colorado resulting in $0.5 million of accelerated depreciation and amortization on the related fixed assets and right-of-use operating lease assets we abandoned. We also incurred $2.3 million of restructuring charges for rent and related expenses, net of sublease income, for previously vacated office spaces and $0.8 million related to non-cash lease impairment charges driven by updated sublease assumptions for our previously vacated office spaces. Other - We incurred $0.3 million of other restructuring charges related to third-party legal and professional advisory fees incurred in connection with the divestiture of our Studer Education practice. Of the total $9.9 million restructuring charge, $7.6 million was recognized in our corporate operations, $1.3 million was recognized in our Healthcare segment, $0.6 million was recognized in our Commercial segment, and $0.4 million was recognized in our Education segment. 2023 In 2023, we incurred $11.6 million of total restructuring charges, which consisted of the following: Employee costs - We incurred $3.0 million of severance-related restructuring expense as a result of strategic workforce adjustments to better align our resources with market demand. Office space reductions - We incurred $8.1 million of restructuring expense related to office space reductions. During 2023, we exited our office spaces in Hillsboro, Oregon and Lexington, Massachusetts, resulting in non-cash impairment charges of $1.9 million and $3.5 million , respectively, on the related operating lease ROU assets and fixed assets. Additionally, in 2023, we recognized $1.8 million for rent and related expenses, net of sublease income, for previously vacated office spaces and $0.9 million related to non-cash lease impairment charges driven by updated sublease assumptions for previously vacated office spaces. Other - We incurred $0.5 million of other restructuring charges, which primarily related to the abandonment of a capitalized software development project. Of the total $11.6 million restructuring charge, $8.2 million was recognized in our corporate operations, $2.0 million was recognized in our Commercial segment, $1.3 million was recognized in our Healthcare segment, and $0.1 million was recognized in our Education segment. 2022 In 2022, we incurred $9.9 million of total restructuring charges, which consisted of the following: Employee costs - We incurred $5.7 million of severance-related restructuring expense as a result of strategic workforce adjustments to better align our resources with market demand. Office space reductions - We incurred $2.5 million of restructuring expense related to office space reductions, of which $2.3 million related to rent and related expenses, net of sublease income, for previously vacated office spaces and $0.2 million related to a non-cash lease impairment charge driven by updated sublease assumptions for a previously vacated office space. Other - We incurred $1.7 million of other restructuring charges, of which $0.7 million related to third-party professional advisory fees related to the modification of our operating model, $0.6 million related to the early termination of a contract, $0.3 million related to accelerated amortization of capitalized software implementation costs for a cloud-computing arrangement that is no longer in use, and $0.1 million related to the divestiture of our Life Sciences business in the fourth quarter of 2021. Of the total $9.9 million restructuring charge, $3.9 million was recognized in our Education segment, $3.7 million was recognized in our corporate operations, $1.6 million was recognized in our Commercial segment, and $0.7 million was recognized in our Healthcare segment. The table below sets forth the changes in the carrying amount of our restructuring charge liability by restructuring type for the years ended December 31, 2024 and 2023. Employee Costs Other Total Balance as of December 31, 2022 $ 3,751 $ 568 $ 4,319 Additions (1) 2,991 — 2,991 Payments (5,376) (74) (5,450) Adjustments (1) — 41 41 Balance as of December 31, 2023 1,366 535 1,901 Additions (1) 2,864 355 3,219 Payments (3,601) (335) (3,936) Adjustments (1) — 13 13 Balance as of December 31, 2024 $ 629 $ 568 $ 1,197 (1) Additions and adjustments exclude non-cash items related to vacated office spaces, such as lease impairment charges and accelerated depreciation on abandoned operating lease ROU assets and fixed assets, which are recorded as restructuring charges on our consolidated statements of operations. All of the $0.6 million restructuring charge liability related to employee costs at December 31, 2024 is expected to be paid in the next 12 months and is included as a component of accrued payroll and related benefits in our consolidated balance sheet. All of the $0.6 million other restructuring charge liability at December 31, 2024, which primarily relates to the early termination of a contract in a prior period, is expected to be paid in the next 12 months and is included as a component of accrued expenses and other current liabilities in our consolidated balance sheet.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activity	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activity	Derivative Instruments and Hedging Activity In the normal course of business, we use forward interest rate swaps to manage the interest rate risk associated with our variable-rate borrowings under our senior secured credit facility and we use non-deliverable foreign exchange forward contracts to manage the foreign currency exchange rate risk related to our Indian Rupee-denominated expenses of our operations in India. From time to time, we may enter into additional forward interest rate swaps or non-deliverable foreign exchange forward contracts to further hedge against our interest rate risk and foreign currency exchange rate risk. We do not use derivative instruments for trading or other speculative purposes. We have designated all of our derivative instruments as cash flow hedges. Therefore, changes in the fair value of the interest rate swaps and foreign exchange forward contracts are recorded to other comprehensive income to the extent effective and reclassified to earnings upon settlement. Interest Rate Swaps We are party to forward interest rate swap agreements with aggregate notional amounts of $250.0 million as of both December 31, 2024 and 2023. Under the terms of the interest rate swap agreements, we receive from the counterparty interest on the notional amount based on one month Term SOFR and we pay to the counterparty a stated, fixed rate. The forward interest rate swap agreements have staggered maturities through January 31, 2029. As of December 31, 2024, it was anticipated that $1.2 million of the gains, net of tax, related to interest rate swaps currently recorded in accumulated other comprehensive income will be reclassified into interest expenses, net of interest income in our consolidated statement of operations within the next 12 months. Foreign Exchange Forward Contracts We are party to non-deliverable foreign exchange forward contracts that are scheduled to mature monthly through December 31, 2025. As of December 31, 2024 and 2023, the aggregate notional amounts of these contracts were INR 1.40 billion, or $16.3 million, and INR 1.38 billion, or $16.6 million, respectively, based on the exchange rates in effect as of each period end. As of December 31, 2024, it was anticipated that all of the $0.3 million losses, net of tax, related to foreign exchange forward contracts currently recorded in accumulated other comprehensive income will be reclassified into direct costs in our consolidated statement of operations within the next 12 months. The table below sets forth additional information relating to our derivative instruments as of December 31, 2024 and 2023. Derivative Instrument Balance Sheet Location December 31, 2024 December 31, 2023 Interest rate swaps Prepaid expenses and other current assets $ 1,600 $ 6,655 Interest rate swaps Other non-current assets 1,381 891 Total Assets $ 2,981 $ 7,546 Interest rate swaps Deferred compensation and other liabilities — 307 Foreign exchange forward contracts Accrued expenses and other current liabilities 381 70 Total Liabilities $ 381 $ 377 All of our derivative instruments are transacted under the International Swaps and Derivatives Association (ISDA) master agreements. These agreements permit the net settlement of amounts owed in the event of default and certain other termination events. Although netting is permitted, it is our policy to record all derivative assets and liabilities on a gross basis on our consolidated balance sheet. Refer to Note 14 “Other Comprehensive Income (Loss)” for additional information on our derivative instruments.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Certain of our assets and liabilities are measured at fair value. Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows: Level 1 Inputs Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 Inputs Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 Inputs Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability. The tables below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2024 and 2023. Level 1 Level 2 Level 3 Total December 31, 2024 Assets: Interest rate swaps $ — $ 2,981 $ — $ 2,981 Convertible debt investment — — 62,344 62,344 Deferred compensation assets — 42,083 — 42,083 Total assets $ — $ 45,064 $ 62,344 $ 107,408 Liabilities: Foreign exchange forward contracts $ — $ 381 $ — $ 381 Contingent consideration for business acquisitions — — 221 221 Total liabilities $ — $ 381 $ 221 $ 602 December 31, 2023 Assets: Interest rate swaps $ — $ 7,546 $ — $ 7,546 Convertible debt investment — — 68,046 68,046 Deferred compensation assets — 34,826 — 34,826 Total assets $ — $ 42,372 $ 68,046 $ 110,418 Liabilities: Interest rate swaps $ — $ 307 $ — $ 307 Foreign exchange forward contracts — 70 — 70 Contingent consideration for business acquisitions — — 2,074 2,074 Total liabilities $ — $ 377 $ 2,074 $ 2,451 Interest rate swaps: The fair values of our interest rate swaps were derived using estimates to settle the interest rate swap agreements, which are based on the net present value of expected future cash flows on each leg of the swaps utilizing market-based inputs and a discount rate reflecting the risks involved. See Note 12 “Derivative Instruments and Hedging Activity” for additional information on our interest rate swaps. Foreign exchange forward contracts: The fair values of our foreign exchange forward contracts were derived using estimates to settle the foreign exchange forward contracts agreements, which are based on the net present value of expected future cash flows on each contract utilizing market-based inputs, including both forward and spot prices, and a discount rate reflecting the risks involved. Refer to Note 12 “Derivative Instruments and Hedging Activity” for additional information on our foreign exchange forward contracts. Deferred compensation assets: We have a non-qualified deferred compensation plan (the “Plan”) for the members of our board of directors and a select group of our employees. The deferred compensation liability is funded by the Plan assets, which consist of life insurance policies maintained within a trust. The cash surrender value of the life insurance policies approximates fair value and is based on third-party broker statements which provide the fair value of the life insurance policies' underlying investments, which are Level 2 inputs. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The Plan assets are included in other non-current assets in our consolidated balance sheets. Realized and unrealized gains (losses) from the deferred compensation assets are recorded to other income (expense), net in our consolidated statements of operations. See Note 15 “Employee Benefit and Deferred Compensation Plans” for additional information on the Plan. Convertible debt investment: Since 2014, we have invested $40.9 million, in the form of 1.69% convertible debt in Shorelight Holdings, LLC (“Shorelight”), the parent company of Shorelight, a U.S.-based company that partners with leading nonprofit universities to increase access to and retention of international students, boost institutional growth, and enhance an institution’s global footprint. The convertible notes will mature on January 17, 2027, unless converted earlier. To determine the appropriate accounting treatment for our investment, we performed a variable interest entity (“VIE”) analysis and concluded that Shorelight does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the convertible notes are not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment to be that of an available-for-sale debt security. We continue to monitor the key factors of our VIE analysis and the terms of the convertible notes to ensure our accounting treatment is appropriate. We have not identified any changes to Shorelight or our investment, that would change our classification of the investment as an available-for-sale debt security. The investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. The carrying value is recorded in long-term investments in our consolidated balance sheets. We estimate the fair value of our investment using a scenario-based approach in the form of a hybrid analysis that consists of a Monte Carlo simulation model and an expected return analysis. The conclusion of value for our investment is based on the probability-weighted assessment of both scenarios. The hybrid analysis utilizes certain assumptions including the assumed holding period through the maturity date of January 17, 2027; the applicable waterfall distribution at the end of the expected holding period based on the rights and privileges of the various instruments; cash flow projections discounted at the risk-adjusted rate of 23.5% and 24.5% as of December 31, 2024 and 2023, respectively; and the concluded equity volatility of 40.0% and 35.0% as of December 31, 2024 and 2023, all of which are Level 3 inputs. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of the investment, which would result in different impacts to our consolidated balance sheet and comprehensive income. Actual results may differ from our estimates. The table below sets forth the changes in the balance of the convertible debt investment for the years ended December 31, 2024 and 2023. Convertible Debt Investment Balance as of December 31, 2022 $ 57,563 Change in fair value of convertible debt investment 10,483 Balance as of December 31, 2023 68,046 Change in fair value of convertible debt investment (5,702) Balance as of December 31, 2024 $ 62,344 Contingent consideration for business acquisitions: We estimate the fair value of acquisition-related contingent consideration using either a probability-weighted assessment of the specific financial performance targets being measured or a Monte Carlo simulation model, as appropriate. These fair value measurements are based on significant inputs not observable in the market and thus represent Level 3 inputs. The significant unobservable inputs used in the fair value measurements of our contingent consideration are our measures of the estimated payouts based on internally generated financial projections on a probability-weighted basis and a discount rate which was 5.6% and 6.3% as of December 31, 2024 and 2023, respectively. The fair value of the contingent consideration is reassessed quarterly based on assumptions used in our latest projections and input provided by practice leaders and management. Any change in the fair value estimate is recorded to other losses (gains), net in our consolidated statement of operations for that period. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of our contingent consideration liability, which would result in different impacts to our consolidated balance sheets and consolidated statements of operations. Actual results may differ from our estimates. The table below sets forth the changes in the balance of the contingent consideration for business acquisitions for the years ended December 31, 2024 and 2023. Contingent Consideration for Business Acquisitions Balance as of December 31, 2022 $ 3,190 Acquisition 374 Payment (1,000) Change in fair value (490) Balance as of December 31, 2023 2,074 Acquisition 36 Payment (1,356) Change in fair value (533) Balance as of December 31, 2024 $ 221 Financial assets and liabilities not recorded at fair value on a recurring basis are as follows: Preferred Stock Investment In the fourth quarter of 2019, we invested $5.0 million in a hospital-at-home company. The investment was made in the form of preferred stock. To determine the appropriate accounting treatment for our preferred stock investment, we performed a VIE analysis and concluded that the company does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the preferred stock is not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment for our investment to be that of an equity security with no readily determinable fair value. We elected to apply the measurement alternative at the time of the purchase and will continue to do so until the investment does not qualify to be so measured. Under the measurement alternative, the investment is carried at cost minus impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment in the same company. On a quarterly basis, we review the information available to determine whether an orderly and observable transaction for the same or similar equity instrument occurred or if factors indicate that a significant decrease in value has occurred. We remeasure to the fair value of the preferred stock using such identified information with changes in the fair value recorded to other income (expense), net in our consolidated statement of operations. The carrying value of the preferred stock investment is recorded in long-term investments in our consolidated balance sheets. In the fourth quarter of 2023, we recognized a non-cash impairment loss of $26.3 million on our preferred stock investment recorded to other income (expense), net in our consolidated statement of operations, based on the valuation established in the most recent financing round. During the first quarter of 2022, we recognized a non-cash unrealized gain of $27.0 million, based on the observable price change of preferred stock issued by the company with similar rights and preferences to our preferred stock, a Level 2 input. There were no observable price changes or factors to indicate that a significant decrease in enterprise value occurred in 2024. Since our initial investment, we have recognized cumulative unrealized gains of $28.6 million and cumulative unrealized losses of $26.3 million. As of both December 31, 2024 and 2023, the carrying value of our preferred stock investment was $7.4 million. Senior Secured Credit Facility The carrying value of our borrowings outstanding under our senior secured credit facility is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the senior secured credit facility bears interest at variable rates based on current market rates as set forth in the Amended Credit Agreement. Refer to Note 7 “Financing Arrangements” for additional information on our senior secured credit facility. Cash and Cash Equivalents and Other Financial Instruments

Other Comprehensive Income (Los

Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Other Comprehensive Income (Loss)	Other Comprehensive Income (Loss) The table below sets forth the components of accumulated other comprehensive income (loss), net of tax for the years ended December 31, 2024, 2023, and 2022. Cash Flow Hedges (1) Foreign Available-for- Interest Rate Swaps Foreign Exchange Forward Contracts Total Balance as of December 31, 2021 $ (1,143) $ 18,374 $ (391) $ — $ 16,840 Foreign currency translation adjustment, net of tax of $0 (1,890) — — — (1,890) Unrealized gain (loss) on investments: Change in fair value, net of tax of $2,209 — (6,146) — — (6,146) Unrealized gain (loss) on cash flow hedges: Interest rate swaps: Change in fair value, net of tax of $(3,555) — — 9,892 — 9,892 Reclassification adjustment into earnings, net of tax of $176 — — (489) — (489) Foreign exchange forward contracts: Change in fair value, net of tax of $43 — — — (120) (120) Reclassification adjustment into earnings, net of tax of $(11) — — — 32 32 Balance as of December 31, 2022 (3,033) 12,228 9,012 (88) 18,119 Foreign currency translation adjustment, net of tax of $0 512 — — — 512 Unrealized gain (loss) on investments: Change in fair value, net of tax of $(2,672) — 7,811 — — 7,811 Unrealized gain (loss) on cash flow hedges: Interest rate swaps: Change in fair value, net of tax of $671 — — 2,068 — 2,068 Reclassification adjustment into earnings, net of tax of $2,020 — — (5,719) — (5,719) Foreign exchange forward contracts: Change in fair value, net of tax of $(13) — — — 34 34 Reclassification adjustment into earnings, net of tax of $(1) — — — 2 2 Balance as of December 31, 2023 (2,521) 20,039 5,361 (52) 22,827 Foreign currency translation adjustment, net of tax of $0 (3,391) — — — (3,391) Unrealized gain (loss) on investments: Change in fair value, net of tax of $1,525 — (4,177) — — (4,177) Unrealized gain (loss) on cash flow hedges: Interest rate swaps: Change in fair value, net of tax of $1,206 — — 3,468 — 3,468 Reclassification adjustment into earnings, net of tax of $2,323 — — (6,609) — (6,609) Foreign exchange forward contracts: Change in fair value, net of tax of $103 — — — (299) (299) Reclassification adjustment into earnings, net of tax of $(24) — — — 67 67 Balance as of December 31, 2024 $ (5,912) $ 15,862 $ 2,220 $ (284) $ 11,886 (1) The before tax amounts reclassified from accumulated other comprehensive income related to our interest rate swaps and foreign exchange forward contracts are recorded to interest expense, net of interest income and direct costs, respectively, on our consolidated statement of operations. The related tax amounts reclassified from accumulated other comprehensive income are recorded to income tax expense (benefit) on our consolidated statement of operations. Refer to Note 12 “Derivative Instruments and Hedging Activity” for additional information on our derivative instruments.

Employee Benefit and Deferred C

Employee Benefit and Deferred Compensation Plans	12 Months Ended
	Dec. 31, 2024
Postemployment Benefits [Abstract]
Employee Benefit and Deferred Compensation Plans	Employee Benefit and Deferred Compensation Plans We sponsor a qualified defined contribution 401(k) plan covering substantially all of our employees. Under the plan, employees are entitled to make pretax, post-tax, and/or Roth post-tax contributions up to the annual maximums established by the Internal Revenue Service. We match an amount equal to the employees’ contributions up to 6% of the employees’ eligible earnings. Our matching contributions for the years ended December 31, 2024, 2023, and 2022 were $41.0 million, $37.0 million, and $31.2 million, respectively.

Equity Incentive Plans

Equity Incentive Plans	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans	Equity Incentive Plans We grant share-based awards under the Company's 2012 Omnibus Incentive Plan (the “2012 Plan”) which permits the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares and other share-based or cash-based awards valued in whole or in part by reference to, or otherwise based on, our common stock. Subsequent to the initial approval of the 2012 Plan and through December 31, 2024, our shareholders approved amendments to the 2012 Plan to increase the number of shares authorized for issuance to 5.4 million, in the aggregate. As of December 31, 2024, 0.8 million shares remain available for issuance under the 2012 Plan. On May 1, 2015, we adopted the Stock Ownership Participation Program (the “SOPP”), which is available to Huron employees below the managing director and principal levels who do not receive equity-based awards as part of their normal compensation plan. Under the SOPP, eligible employees may elect to use after-tax payroll deductions or cash contributions to purchase shares of the Company’s common stock on certain designated purchase dates. Employees who purchase stock under the SOPP are granted restricted stock equal to 25% of their purchased shares. Vesting of the restricted stock is subject to both a time-based vesting schedule and a requirement that the purchased shares be held for a specified period. Subsequent to the initial approval of the SOPP and through December 31, 2024, our shareholders approved amendments to the SOPP to increase the total number of shares authorized for issuance to 0.9 million, in the aggregate. As of December 31, 2024, 0.2 million shares remain available for issuance under the SOPP. It has been our practice to issue shares of common stock upon exercise of stock options and granting of restricted stock from authorized but unissued shares, with the exception of the SOPP under which shares are issued from treasury stock. Certain grants of restricted stock under the 2012 Plan may be issued from treasury stock at the direction of the Compensation Committee. The Compensation Committee of the board of directors has the responsibility of interpreting the 2012 Plan and SOPP and determining all of the terms and conditions of awards made under the plans, including when the awards will become exercisable or otherwise vest. Share-based awards outstanding under our 2012 Plan provide for a retirement eligibility provision, under which eligible employees who have reached 62 years of age and have completed seven years of employment with Huron will continue vesting in their share-based awards after retirement, subject to certain conditions. Total share-based compensation cost recognized for the years ended December 31, 2024, 2023, and 2022 was $45.1 million, $45.7 million, and $31.0 million, respectively, with related income tax benefits of $9.4 million, $9.3 million, and $6.8 million, respectively. The $45.1 million of shared-based compensation cost recognized in 2024 included $0.5 million recorded to restructuring charges as it related to the modification of certain nonvested share-based compensation awards to accelerate vesting upon the completed sale of the Studer Education practice. As of December 31, 2024, there was $64.4 million of total unrecognized compensation cost related to nonvested share-based awards. This cost is expected to be recognized over a weighted average period of 2.8 years. Restricted Stock The grant date fair values of our restricted stock are measured based on the fair value of our common stock at grant date and amortized into expense over the service period. Subject to acceleration under certain conditions, the majority of our restricted stock vests annually over four years. The table below summarizes the restricted stock activity for the year ended December 31, 2024. Number of Shares Weighted 2012 Omnibus Incentive Plan Stock Ownership Participation Program Total Nonvested restricted stock at December 31, 2023 926 17 943 $ 63.00 Granted 355 21 376 $ 98.94 Vested (388) (17) (405) $ 61.32 Forfeited (76) (2) (78) $ 77.14 Nonvested restricted stock at December 31, 2024 817 19 836 $ 78.68 The aggregate fair value of restricted stock that vested during the years ended December 31, 2024, 2023, and 2022 was $40.3 million, $27.6 million, and $18.4 million, respectively. The weighted average grant date fair value per share of restricted stock granted during 2023 and 2022 was $80.84 and $49.69, respectively. Performance-based Share Awards The total number of shares earned by recipients of performance-based share awards is contingent upon meeting practice specific and/or company-wide performance goals. Following the performance period, certain awards are subject to the completion of a service period, which is generally an additional two years. These earned awards vest on a graded vesting schedule over the service period. For certain performance awards, the recipients may earn additional shares of stock for performance achieved above the stated target. The grant date fair values of our performance-based share awards are measured based on the fair value of our common stock at grant date. Compensation cost is amortized into expense over the service period, including the performance period. The table below summarizes the performance-based stock activity for the year ended December 31, 2024. All nonvested performance-based stock outstanding at December 31, 2024 and 2023 was granted under the 2012 Omnibus Incentive Plan. Number of Weighted Nonvested performance-based stock at December 31, 2023 454 $ 60.72 Granted (1) 265 $ 99.40 Vested (264) $ 53.29 Forfeited (2) (34) $ 78.93 Nonvested performance-based stock at December 31, 2024 (3) 421 $ 78.27 (1) Shares granted in 2024 are presented at the stated target, which represents the base number of shares that could be earned. Actual shares earned may be below or, for certain grants, above the target based on the achievement of specific financial goals. (2) Forfeited shares include shares forfeited as a result of not meeting the performance criteria of the award as well as shares forfeited upon termination. (3) Of the 421,000 nonvested performance-based shares outstanding as of December 31, 2024, 327,236 shares were unearned and subject to achievement of specific financial goals. Once earned, the awards will be subject to time-based vesting according to the terms of the award. Based on 2024 financial results, approximately 67,451 of the 327,236 unearned shares will be forfeited in the first quarter of 2025. The aggregate fair value of performance-based stock that vested during the years ended December 31, 2024, 2023, and 2022 was $25.9 million , $5.9 million, and $5.8 million, respectively. The weighted average grant date fair value per share of performance-based stock granted during 2023 and 2022 was $80.89 and $48.22, respectively. Performance-based Stock Options Beginning in 2022, the Company granted performance-based stock options which are earned by the recipients contingent upon meeting practice specific goals. Following the performance period, these awards are subject to the completion of a service period of an additional two years. These earned awards vest on a graded vesting schedule over the service period. The performance-based stock options were granted at exercise prices equal to the fair value of the Company’s common stock on the date of grant. Compensation cost is amortized into expense over the service period, including the performance period. Our performance-based stock options have a contractual term of 7 years. The fair values of the performance-based stock options granted during 2024 and 2023 were calculated using the Black-Scholes option pricing model using the following assumptions: 2024 2023 2022 Black-Scholes performance-based option pricing model: Expected dividend yield —% —% —% Expected volatility 40.0% 40.0% 40.0% Risk-free rate 4.2% 4.4% 1.6% / 2.6% Expected option life (in years) 4.5 years 4.5 years 4.5 years Expected volatility was based on our historical stock prices as we believe that our historical volatility provides the most reliable indication of future volatility and sufficient historical daily stock price observations are available. The risk-free interest rate was based on the rate of U.S. Treasury bills with an equivalent expected term of the stock options at the time of the option grant. The expected option life was estimated using the simplified method, which is a weighted average of the vesting term and the contractual term, to determine the expected term. The simplified method was used due to the lack of sufficient data available to provide a reasonable basis upon which to estimate the expected term. Performance-based stock option activity for the year ended December 31, 2024 was as follows: Number Weighted Weighted Aggregate Outstanding at December 31, 2023 181 $ 63.73 5.5 $ 7.1 Granted (2) 42 $ 99.40 Exercised (33) $ 55.55 $ 1.6 Forfeited or expired (26) $ 76.90 Outstanding at December 31, 2024 (1)(3) 164 $ 72.44 5.0 $ 8.5 Exercisable at December 31, 2024 48 $ 59.82 4.5 $ 3.1 (1) All of the outstanding performance-based stock options were granted under the 2012 Omnibus Incentive Plan. (2) Performance-based stock options granted in 2024 are presented at the stated target, which represents the base number of options that could be earned. Actual options earned may be below or, for certain grants, above the target based on the achievement of specific financial goals. (3) Of the 164,000 outstanding performance-based stock options as of December 31, 2024, 39,327 were unearned and subject to achievement of specific financial goals. Once earned, the options will be subject to time-based vesting according to the terms of the award. Based on 2024 financial results, approximately 28,138 of the 39,327 unearned options will be forfeited in the first quarter of 2025. The weighted average grant date fair value of the performance-based stock options granted during 2024, 2023, and 2022 was $39.10, $32.27, and $17.00, respectively. The aggregate intrinsic value of performance-based stock options exercised during 2023 was $0.8 million. No performance-based stock options were exercised in 2022. Time-vested Stock Options In prior years, we have granted stock options to certain employees that are solely earned based on the completion of the stated service period. These time-vested stock options were granted at exercise prices equal to the fair value of the Company’s common stock on the date of grant. No time-vested stock option awards were granted in 2024, 2023, or 2022. Subject to acceleration under certain conditions, these time-vested stock options vest annually over four years. Our time-vested stock options have a contractual term between 7 and 10 years. Expected volatility was based on our historical stock prices as we believe that our historical volatility provides the most reliable indication of future volatility and sufficient historical daily stock price observations are available. The risk-free interest rate was based on the rate of U.S. Treasury bills with an equivalent expected term of the stock options at the time of the option grant. The expected option life was estimated using the simplified method, which is a weighted average of the vesting term and the contractual term, to determine the expected term. The simplified method was used due to the lack of sufficient data available to provide a reasonable basis upon which to estimate the expected term. Time-vested stock option activity for the year ended December 31, 2024 was as follows: Number Weighted Weighted Aggregate Outstanding at December 31, 2023 25 $ 52.49 4.7 $ 1.3 Granted — Exercised — Forfeited or expired — Outstanding at December 31, 2024 (1) 25 $ 52.49 3.8 $ 1.8 Exercisable at December 31, 2024 13 $ 52.49 3.8 $ 0.9 (1) All of the outstanding time-vested stock options were granted under the 2012 Omnibus Incentive Plan. No time-vested stock options were granted in 2024, 2023, and 2022. The aggregate intrinsic value of time-vested stock options exercised during 2023 and 2022 was $1.5 million and $0.5 million, respectively.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The income tax expense (benefit) for the years ended December 31, 2024, 2023, and 2022 consisted of the following: Year Ended December 31, 2024 2023 2022 Current taxes: Federal $ 18,345 $ 15,229 $ 7,130 State 7,645 5,816 2,987 Foreign 8,787 6,553 4,123 Total current expense 34,777 27,598 14,240 Deferred taxes: Federal 2,385 (4,516) 14,645 State 468 (936) 4,039 Foreign (240) (730) 101 Total deferred expense (benefit) 2,613 (6,182) 18,785 Income tax expense $ 37,390 $ 21,416 $ 33,025 The components of income before taxes were as follows: Year Ended December 31, 2024 2023 2022 U.S. $ 122,080 $ 63,935 $ 90,907 Foreign 31,936 19,960 17,670 Total $ 154,016 $ 83,895 $ 108,577 A reconciliation of the U.S. statutory income tax rate to our effective tax rate is as follows: Year Ended December 31, 2024 2023 2022 Percent of pretax income: At U.S. statutory tax rate 21.0 % 21.0 % 21.0 % State income taxes, net of federal benefit 4.8 5.8 6.1 Disallowed executive compensation 1.7 3.7 1.9 Valuation allowance 0.6 0.4 2.6 Disallowed meals and entertainment 0.6 0.9 0.1 Stock-based compensation (3.5) (2.9) 0.1 Tax credits (0.7) (1.8) (1.0) Realized investment losses/gains (0.6) (1.2) 1.4 Foreign source income (0.2) 0.2 1.2 Deferred tax adjustments — (0.3) (2.7) Other 0.6 (0.3) (0.3) Effective income tax rate 24.3 % 25.5 % 30.4 % The net deferred tax asset (liability) balance at December 31, 2024 and 2023 consisted of the following: As of December 31, 2024 2023 Deferred tax assets: Share-based compensation $ 13,216 $ 12,343 Operating lease liabilities 11,687 13,635 Deferred compensation liability 10,944 9,048 Accrued payroll and payroll related liabilities 10,086 4,541 Net operating loss carryforwards 3,553 3,508 Tax credits 2,164 1,609 Other 3,954 4,210 Total deferred tax assets 55,604 48,894 Valuation allowance (6,561) (5,679) Net deferred tax assets 49,043 43,215 Deferred tax liabilities: Intangibles and goodwill (51,526) (44,454) Operating lease right-of-use assets (5,756) (6,898) Convertible debt investment (5,542) (7,067) Prepaid expenses (4,811) (2,917) Property and equipment (1,448) (2,547) Other (5,860) (5,204) Total deferred tax liabilities (74,943) (69,087) Net deferred tax liabilities $ (25,900) $ (25,872) As of December 31, 2024 and 2023, we had valuation allowances of $6.6 million and $5.7 million, respectively, primarily due to uncertainties relating to the ability to utilize deferred tax assets recorded for foreign losses and tax credits. The increase in valuation allowances in 2024 primarily related to an increase in foreign tax credits carryforwards. The Company has foreign net operating losses of $3.5 million which begin to expire in 2027, if not utilized. We have federal tax credit carryforwards of $2.2 million which will begin to expire in 2030, if not utilized. We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution. A reconciliation of our beginning and ending amount of unrecognized tax benefits is as follows: Unrecognized Tax Benefits Balance at January 1, 2022 $ 744 Decrease due to lapse of statute of limitations (101) Decrease based on tax positions related to prior years (50) Balance at December 31, 2022 593 Decrease due to lapse of statute of limitations (593) Balance at December 31, 2023 — Balance at December 31, 2024 $ — As of both December 31, 2024 and 2023, there was no unrecognized tax benefit which would affect the effective tax rate if recognized. As of both December 31, 2024 and 2023, no potential payment of interest and penalties was accrued. When we accrue interest and penalties, we record as a component of provision for income taxes on our consolidated statement of earnings. We file income tax returns with federal, state, local and foreign jurisdictions. Tax years 2021 through 2023 are subject to future examinations by federal tax authorities. Tax years 2018 through 2023 are subject to future examinations by state and local tax authorities. The Company is currently under audit by the state of Wisconsin. Our foreign income tax filings are subject to future examinations by the local foreign tax authorities for tax years 2019 through 2023. The Company is currently under audit by the governments of India and Singapore. We do not expect the outcome of these audits to have a material adverse effect on our financial position or results of operations.

Commitments, Contingencies and

Commitments, Contingencies and Guarantees	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments, Contingencies and Guarantees	Commitments, Contingencies and Guarantees Lease Commitments We lease office space, data centers and certain equipment under non-cancelable operating lease arrangements expiring on various dates through 2030, with various renewal options. Office facilities under operating leases include fixed payments plus, in some cases, scheduled base rent increases over the term of the lease. Certain leases require variable payments of real estate taxes, insurance and operating expenses. See Note 5 “Leases” for additional information on our leases, including the remaining expected lease payments under our operating leases as of December 31, 2024. Litigation In the second quarter of 2024, we recognized a $15.0 million pre-tax litigation settlement gain related to a completed legal matter in which Huron was the plaintiff, which is included in other gains, net on our consolidated statement of operations. As of December 31, 2024, all of the $15.0 million settlement was received. From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Annual Report on Form 10-K, we are not a party to any litigation or legal proceeding or subject to any claim that, in the current opinion of management, could reasonably be expected to have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results. Guarantees Guarantees in the form of letters of credit totaling $0.4 million and $0.5 million were outstanding at December 31, 2024 and 2023, respectively, which are used as security deposits for our office facilities. In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. As of December 31, 2024 and 2023, the total estimated fair value of our outstanding contingent consideration liability was $0.2 million and $2.1 million, respectively. To the extent permitted by law, our bylaws and articles of incorporation require that we indemnify our officers and directors against judgments, fines and amounts paid in settlement, including attorneys’ fees, incurred in connection with civil or criminal action or proceedings, as it relates to their services to us if such person acted in good faith. Although there is no limit on the amount of indemnification, we may have recourse against our insurance carrier for certain payments made.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information We provide our services and products and manage our business under three reportable segments: Healthcare, Education, and Commercial, which align our business by industry. • Healthcare Our Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; the federal health system; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups; payors; and long-term care or post-acute providers. Our healthcare-focused services and products include financial and operational performance improvement consulting, which spans revenue cycle, business operations and care delivery transformation; digital offerings, spanning technology and analytic-related services, which includes enterprise health record (“EHR”), enterprise resource planning (“ERP”) and enterprise performance management (“EPM”), customer relationship management (“CRM”), data management, artificial intelligence (“AI”) and automation, and technology managed services, and a portfolio of software products; organizational transformation; revenue cycle managed services and outsourcing; financial and capital advisory consulting; and strategy and innovation consulting. • Education Our Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations and other education-related organizations. Our education and research-focused services and products include our digital offerings, spanning technology and analytic-related services, including student information systems, ERP and EPM, CRM, data management, AI and automation, and technology managed services and our Huron Research Suite product suite (the leading software suite designed to facilitate and improve research administration service delivery and compliance); our research-focused consulting and managed services; our strategy and operations consulting services, which span finance, accounting, operations and athletics to organization and talent strategy and student and academic strategy; and our global philanthropy consulting services. • Commercial Our Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Our Commercial professionals work primarily with six primary buyers: the chief executive officer, the chief financial officer, the chief strategy officer, the chief human resources officer, the chief operating officer, and organizational advisors, including lenders and law firms. We have a deep focus on serving organizations in the financial services, energy and utilities, industrials and manufacturing industries and the public sector while opportunistically serving commercial industries more broadly, including professional and business services, life sciences, consumer products, and retail. Our Commercial professionals use their deep industry, functional and technical expertise to deliver our digital services and software products, financial and capital advisory (special situation advisory and corporate finance advisory) consulting services, and strategy and innovation consulting services. Our chief operating decision maker ("CODM"), who is our chief executive officer, manages the business under these three reportable segments. Our CODM uses segment operating income in the annual budgeting and quarterly forecasting process as well as on a monthly basis for evaluating the performance of each segment and making decisions about allocating capital and other resources to each segment. Our CODM does not evaluate segments using asset information. Segment operating income consists of the revenues generated by a segment, less operating expenses that are incurred directly by the segment. Unallocated costs include corporate costs related to administrative functions that are performed in a centralized manner, as well as restructuring charges, depreciation and amortization, and interest expense that are not attributable to a particular segment. The administrative function costs include corporate office support costs, office facility costs, costs related to accounting and finance, human resources, legal, marketing, information technology, and company-wide business development functions, as well as costs related to overall corporate management. The tables below set forth information about our operating segments for the years ended December 31, 2024, 2023, and 2022, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements. We do not present financial information by geographic area because the financial results of our international operations are not significant to our consolidated financial statements. Year Ended December 31, 2024 2023 2022 Healthcare: Revenues before reimbursable expenses $ 756,263 $ 673,989 $ 534,999 Reimbursable expenses 21,174 22,324 16,347 Total revenues 777,437 696,313 551,346 Operating expenses: Direct costs 489,123 452,080 360,823 Reimbursable expenses 21,174 22,332 16,463 Selling, general and administrative expenses 49,728 41,351 36,155 Depreciation and amortization 7,162 6,373 6,015 Other segment items (1) 1,322 1,277 663 Total segment operating expenses 568,509 523,413 420,119 Segment operating income $ 208,928 $ 172,900 $ 131,227 Education: Revenues before reimbursable expenses $ 474,221 $ 429,663 $ 359,835 Reimbursable expenses 9,320 9,229 5,988 Total revenues 483,541 438,892 365,823 Operating expenses: Direct costs 337,607 308,800 257,603 Reimbursable expenses 9,320 9,311 6,083 Year Ended December 31, 2024 2023 2022 Selling, general and administrative expenses 25,472 21,128 18,795 Depreciation and amortization 1,912 437 492 Other segment items (1) 709 118 3,926 Total segment operating expenses 375,020 339,794 286,899 Segment operating income $ 108,521 $ 99,098 $ 78,924 Commercial: Revenues before reimbursable expenses $ 255,601 $ 258,408 $ 237,621 Reimbursable expenses 5,226 5,142 4,171 Total revenues 260,827 263,550 241,792 Operating expenses: Direct costs 183,250 181,812 167,398 Reimbursable expenses 5,223 5,123 4,126 Selling, general and administrative expenses 20,371 20,251 18,003 Depreciation and amortization 223 210 582 Other segment items (1) 562 1,952 1,658 Total segment operating expenses 209,629 209,348 191,767 Segment operating income $ 51,198 $ 54,202 $ 50,025 Total Huron: Revenues before reimbursable expenses $ 1,486,085 $ 1,362,060 $ 1,132,455 Reimbursable expenses 35,720 36,695 26,506 Total revenues $ 1,521,805 $ 1,398,755 $ 1,158,961 Segment operating income $ 368,647 $ 326,200 $ 260,176 Items not allocated at the segment level: Unallocated corporate expenses 191,180 175,206 136,677 Other gains, net (14,466) (444) (218) Restructuring charges 7,590 8,204 3,686 Depreciation and amortization 15,524 17,886 20,271 Operating income 168,819 125,348 99,760 Other income (expense), net (14,803) (41,453) 8,817 Income before taxes $ 154,016 $ 83,895 $ 108,577 (1) Other segment items in each segment primarily consists of restructuring charges for all periods presented. The following tables illustrate the disaggregation of segment total revenues and segment revenues before reimbursable expenses by our two principal capabilities: i) Consulting and Managed Services and ii) Digital, and includes a reconciliation to consolidated total revenues and consolidated revenues before reimbursable expenses. We manage our business on the basis of revenues before reimbursable expenses, which we believe is the most accurate reflection of our services because it eliminates the effect of reimbursable expenses that we bill to our clients at cost. Year Ended December 31, Total Revenues by Capability 2024 2023 2022 Healthcare: Consulting and Managed Services $ 549,686 $ 493,263 $ 377,617 Digital 227,751 203,050 173,729 Total revenues $ 777,437 $ 696,313 $ 551,346 Education: Consulting and Managed Services $ 245,358 $ 219,098 $ 195,204 Digital 238,183 219,794 170,619 Total revenues $ 483,541 $ 438,892 $ 365,823 Commercial: Consulting and Managed Services $ 90,441 $ 92,182 $ 82,604 Digital 170,386 171,368 159,188 Total revenues $ 260,827 $ 263,550 $ 241,792 Total Huron: Consulting and Managed Services $ 885,485 $ 804,543 $ 655,425 Digital 636,320 594,212 503,536 Total revenues $ 1,521,805 $ 1,398,755 $ 1,158,961 Year Ended December 31, Revenues before Reimbursable Expenses by Capability 2024 2023 2022 Healthcare: Consulting and Managed Services $ 533,846 $ 476,726 $ 365,645 Digital 222,417 197,263 169,354 Total revenues before reimbursable expenses $ 756,263 $ 673,989 $ 534,999 Education: Consulting and Managed Services $ 240,985 $ 214,971 $ 192,336 Digital 233,236 214,692 167,499 Total revenues before reimbursable expenses $ 474,221 $ 429,663 $ 359,835 Commercial: Consulting and Managed Services $ 89,028 $ 90,323 $ 80,013 Digital 166,573 168,085 157,608 Total revenues before reimbursable expenses $ 255,601 $ 258,408 $ 237,621 Total Huron: Consulting and Managed Services $ 863,859 $ 782,020 $ 637,994 Digital 622,226 580,040 494,461 Total revenues before reimbursable expenses $ 1,486,085 $ 1,362,060 $ 1,132,455 For the years ended December 31, 2024, 2023, and 2022, substantially all of our revenues were recognized over time.

Valuation and Qualifying Accoun

Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Valuation and Qualifying Accounts	Valuation and Qualifying Accounts The table below sets forth the changes in the carrying amount of our allowances for doubtful accounts and unbilled services and valuation allowance for deferred tax assets for the years ended December 31, 2024, 2023, and 2022. Allowances for doubtful accounts and unbilled services includes allowances for fee adjustments and other discretionary pricing adjustments as well as allowances related to clients' inability to make required payments on accounts receivable. Beginning Additions (1) Deductions Ending Year ended December 31, 2022: Allowances for doubtful accounts and unbilled services $ 15,795 17,820 11,480 $ 22,135 Valuation allowance for deferred tax assets $ 2,876 3,421 630 $ 5,667 Year ended December 31, 2023: Allowances for doubtful accounts and unbilled services $ 22,135 30,570 23,461 $ 29,244 Valuation allowance for deferred tax assets $ 5,667 239 227 $ 5,679 Year ended December 31, 2024: Allowances for doubtful accounts and unbilled services $ 29,244 24,520 35,346 $ 18,418 Valuation allowance for deferred tax assets $ 5,679 1,035 153 $ 6,561 (1)

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Event [Pending]

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net income	$ 116,626	$ 62,479	$ 75,552

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024 shares
Trading Arrangements, by Individual
Name	C. Mark Hussey
Title	Chief Executive Officer, President and Director
Rule 10b5-1 Arrangement Adopted	true
Non-Rule 10b5-1 Arrangement Adopted	false
Adoption Date	11/21/2024
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Expiration Date	11/20/2025
Aggregate Available	29,363

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Cybersecurity Risk Management a

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	We recognize the importance of assessing, identifying, and managing material risks associated with cybersecurity threats, as such term is defined in Item 106(a) of Regulation S-K. Accordingly, the company takes a comprehensive approach to identifying and managing cybersecurity risks that involves the company's Information Security functional team, senior management, and our board of directors in coordination with the Technology and Information Security (“T&IS”) Committee and the Audit Committee of our board of directors. Our cybersecurity risk management function is a component of our overall approach to risk management, including coordination with our Enterprise Risk Management Committee. Our cybersecurity risks include, among other things: operational risks, malicious attacks, improper employee or contractor access, harm to employees or customers and violation of data privacy, intellectual property or security laws. Although, as of the date of this Form 10-K, Huron has not experienced a cybersecurity incident that resulted in a material adverse impact to our business or operations, there can be no guarantee that we will not experience such an incident in the future. Further details about the cybersecurity risks we face are described under Item 1A. “Risk Factors.” We have a cybersecurity program that focuses on implementing risk-based controls, technologies, and other processes. We aim to incorporate industry best practices throughout our cybersecurity program, including the frameworks established by the National Institute of Standards and Technology (“NIST”), the Cybersecurity and Infrastructure Security Agency (“CISA”), and other applicable industry standards. To augment our in-house capabilities, we leverage expertise from professional services firms and/or outside counsel, as needed, to assess our cybersecurity controls, and collaborate on an ever-changing landscape. Our cybersecurity program conforms with ISO/IEC 27001:2022 and our most recent recertification was in 2024. We use various mechanisms to detect and monitor cybersecurity threats, including monitoring unusual network activity, conducting annual security awareness training for employees, deploying phishing test campaigns, maintaining containment and incident response tools, and reviewing, updating and improving our Incident Response Plan annually. We also conduct tabletop exercises to simulate responses to cybersecurity incidents. During these exercises, our team of cybersecurity professionals collaborate with technical and business stakeholders across the organization to further analyze the risk to the company and form detection, mitigation, and remediation improvements. We also engage third parties, including assessors, consultants, and auditors to assess our cybersecurity control environment and to test the vulnerability of our cybersecurity infrastructure at least annually. Our risk management program also assesses risks associated with third-party service providers. S uch providers are subject to an onboarding process and may be reevaluated periodically. We use a variety of inputs in such risk assessments, including information supplied by the providers themselves and other third parties. In addition, our contracts with our service providers require them to adhere to mutually agreed upon security requirements, controls and responsibilities, as applicable.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	We have a cybersecurity program that focuses on implementing risk-based controls, technologies, and other processes. We aim to incorporate industry best practices throughout our cybersecurity program, including the frameworks established by the National Institute of Standards and Technology (“NIST”), the Cybersecurity and Infrastructure Security Agency (“CISA”), and other applicable industry standards. To augment our in-house capabilities, we leverage expertise from professional services firms and/or outside counsel, as needed, to assess our cybersecurity controls, and collaborate on an ever-changing landscape. Our cybersecurity program conforms with ISO/IEC 27001:2022 and our most recent recertification was in 2024.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]	Although, as of the date of this Form 10-K, Huron has not experienced a cybersecurity incident that resulted in a material adverse impact to our business or operations, there can be no guarantee that we will not experience such an incident in the future.
Cybersecurity Risk Board of Directors Oversight [Text Block]	Our cybersecurity program is overseen by the leaders of our Information Security functional team, which is led by our Chief Information Officer (“CIO”) who has over 30 years of relevant work experience. Prior to joining Huron in 2018, our CIO served in various information security and information technology roles in the professional services industry for several large, public companies and executed large-scale, global implementations of business applications and infrastructure technologies in a manner designed to mitigate cybersecurity risks. Our CIO reports on a quarterly basis to Huron's internal Information Security Management System (“ISMS”) Committee, which has the primary responsibility for assessing and managing material cybersecurity risks. The ISMS Committee, which includes members of our executive and senior leadership teams, our CIO and other functional team leaders, reviews, approves and establishes ISMS specific goals and objectives, reviews policy updates and approves the annual IT risk assessment, which identifies impacts, threats and controls related to IT assets utilized across the enterprise. Our board of directors, in coordination with its T&IS Committee, oversees the governance of the Company’s technology-related risks, including information security, data protection, cybersecurity, vendor, fraud, and business continuity risks, and technology-related strategies. The T&IS Committee receives quarterly updates from the CIO, including existing and new cybersecurity risks, the management and/or mitigation of such risks, material cybersecurity incidents (if any), and status on key cybersecurity initiatives. Our board also actively participates in discussions with management on cybersecurity-related news events and discusses any updates to our cybersecurity risk management and strategy programs.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	Our cybersecurity program is overseen by the leaders of our Information Security functional team, which is led by our Chief Information Officer (“CIO”) who has over 30 years of relevant work experience. Prior to joining Huron in 2018, our CIO served in various information security and information technology roles in the professional services industry for several large, public companies and executed large-scale, global implementations of business applications and infrastructure technologies in a manner designed to mitigate cybersecurity risks. Our CIO reports on a quarterly basis to Huron's internal Information Security Management System (“ISMS”) Committee, which has the primary responsibility for assessing and managing material cybersecurity risks. The ISMS Committee, which includes members of our executive and senior leadership teams, our CIO and other functional team leaders, reviews, approves and establishes ISMS specific goals and objectives, reviews policy updates and approves the annual IT risk assessment, which identifies impacts, threats and controls related to IT assets utilized across the enterprise. Our board of directors, in coordination with its T&IS Committee, oversees the governance of the Company’s technology-related risks, including information security, data protection, cybersecurity, vendor, fraud, and business continuity risks, and technology-related strategies. The T&IS Committee receives quarterly updates from the CIO, including existing and new cybersecurity risks, the management and/or mitigation of such risks, material cybersecurity incidents (if any), and status on key cybersecurity initiatives. Our board also actively participates in discussions with management on cybersecurity-related news events and discusses any updates to our cybersecurity risk management and strategy programs.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	Our board of directors, in coordination with its T&IS Committee, oversees the governance of the Company’s technology-related risks, including information security, data protection, cybersecurity, vendor, fraud, and business continuity risks, and technology-related strategies. The T&IS Committee receives quarterly updates from the CIO, including existing and new cybersecurity risks, the management and/or mitigation of such risks, material cybersecurity incidents (if any), and status on key cybersecurity initiatives. Our board also actively participates in discussions with management on cybersecurity-related news events and discusses any updates to our cybersecurity risk management and strategy programs.
Cybersecurity Risk Role of Management [Text Block]	Our CIO reports on a quarterly basis to Huron's internal Information Security Management System (“ISMS”) Committee, which has the primary responsibility for assessing and managing material cybersecurity risks. The ISMS Committee, which includes members of our executive and senior leadership teams, our CIO and other functional team leaders, reviews, approves and establishes ISMS specific goals and objectives, reviews policy updates and approves the annual IT risk assessment, which identifies impacts, threats and controls related to IT assets utilized across the enterprise.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	Our cybersecurity program is overseen by the leaders of our Information Security functional team, which is led by our Chief Information Officer (“CIO”) who has over 30 years of relevant work experience. Prior to joining Huron in 2018, our CIO served in various information security and information technology roles in the professional services industry for several large, public companies and executed large-scale, global implementations of business applications and infrastructure technologies in a manner designed to mitigate cybersecurity risks. Our CIO reports on a quarterly basis to Huron's internal Information Security Management System (“ISMS”) Committee, which has the primary responsibility for assessing and managing material cybersecurity risks. The ISMS Committee, which includes members of our executive and senior leadership teams, our CIO and other functional team leaders
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	Our cybersecurity program is overseen by the leaders of our Information Security functional team, which is led by our Chief Information Officer (“CIO”) who has over 30 years of relevant work experience. Prior to joining Huron in 2018, our CIO served in various information security and information technology roles in the professional services industry for several large, public companies and executed large-scale, global implementations of business applications and infrastructure technologies in a manner designed to mitigate cybersecurity risks. Our CIO reports on a quarterly basis to Huron's internal Information Security Management System (“ISMS”) Committee, which has the primary responsibility for assessing and managing material cybersecurity risks. The ISMS Committee, which includes members of our executive and senior leadership teams, our CIO and other functional team leaders,
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	Our CIO reports on a quarterly basis to Huron's internal Information Security Management System (“ISMS”) Committee, which has the primary responsibility for assessing and managing material cybersecurity risks. The ISMS Committee, which includes members of our executive and senior leadership teams, our CIO and other functional team leaders, reviews, approves and establishes ISMS specific goals and objectives, reviews policy updates and approves the annual IT risk assessment, which identifies impacts, threats and controls related to IT assets utilized across the enterprise.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Earnings Per Share (Policies)

Earnings Per Share (Policies)	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Earnings Per Share, Policy	Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, unvested restricted stock units, and outstanding common stock options, to the extent dilutive. In periods for which we report a net loss, diluted weighted average common shares outstanding excludes all potential common stock equivalents as their impact on diluted net loss per share would be anti-dilutive.

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Policies)	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives, Policy [Policy Text Block]	The table below sets forth additional information relating to our derivative instruments as of December 31, 2024 and 2023. Derivative Instrument Balance Sheet Location December 31, 2024 December 31, 2023 Interest rate swaps Prepaid expenses and other current assets $ 1,600 $ 6,655 Interest rate swaps Other non-current assets 1,381 891 Total Assets $ 2,981 $ 7,546 Interest rate swaps Deferred compensation and other liabilities — 307 Foreign exchange forward contracts Accrued expenses and other current liabilities 381 70 Total Liabilities $ 381 $ 377

Fair Value of Financial Instr_2

Fair Value of Financial Instruments - (Policies)	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Fair value measurement policy	Certain of our assets and liabilities are measured at fair value. Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows: Level 1 Inputs Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 Inputs Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 Inputs Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.

Income Taxes - (Policies)

Income Taxes - (Policies)	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate resolution.

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in Carrying Amount of Goodwill	The table below sets forth the changes in the carrying amount of goodwill by reportable segment for the years ended December 31, 2024 and 2023. Healthcare Education Commercial Total Balance as of December 31, 2022: Goodwill $ 644,238 $ 123,652 $ 312,968 $ 1,080,858 Accumulated impairment losses (190,024) (1,417) (264,451) (455,892) Goodwill, net as of December 31, 2022 $ 454,214 $ 122,235 $ 48,517 $ 624,966 Goodwill recorded in connection with a business combination (1) 745 — — 745 Balance as of December 31, 2023: Goodwill $ 644,983 $ 123,652 $ 312,968 $ 1,081,603 Accumulated impairment losses (190,024) (1,417) (264,451) (455,892) Goodwill, net as of December 31, 2023 $ 454,959 $ 122,235 $ 48,517 $ 625,711 Goodwill recorded in connection with business combinations (1) 869 22,476 32,134 55,479 Goodwill allocated to disposal of business (2) (2,300) — — (2,300) Foreign currency translation — (147) — (147) Balance as of December 31, 2024: Goodwill $ 643,552 $ 145,981 $ 345,102 $ 1,134,635 Accumulated impairment losses (190,024) (1,417) (264,451) (455,892) Goodwill, net as of December 31, 2024: $ 453,528 $ 144,564 $ 80,651 $ 678,743 (1) See Note 3 “Acquisitions and Divestiture” for additional information on business combinations completed in 2024, 2023 and 2022. (2) In 2024, we completed the divestiture of our Studer Education practice within our Healthcare segment, and allocated a portion of goodwill within the Healthcare segment to the disposed practice based on the relative fair values of Studer Education and the remaining segment. The allocated goodwill of $2.3 million was written off and included in the gain on sale of Studer Education. The sale of Studer Education did not meet the criteria for reporting separately as discontinued operations. In connection with the sale, we recorded a $3.6 million pretax gain which is included in other income (expense), net in our consolidated statements of operations.
Intangible Assets	Intangible assets as of December 31, 2024 and 2023 consisted of the following: As of December 31, 2024 2023 Useful Life Gross Accumulated Gross Accumulated Customer relationships 5 to 10 $ 30,683 $ 9,790 $ 60,636 $ 48,928 Technology and software 2 to 5 16,230 12,771 16,230 10,195 Trade names 6 6,000 6,000 6,000 6,000 Customer contracts 2 to 4 1,483 418 — — Non-competition agreements 2 to 5 1,260 601 720 389 Total $ 55,656 $ 29,580 $ 83,586 $ 65,512
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	The table below sets forth the estimated annual amortization expense for each of the five succeeding years for the intangible assets recorded as of December 31, 2024. Year Ending December 31, Estimated 2025 $ 7,632 2026 $ 5,882 2027 $ 4,480 2028 $ 3,606 2029 $ 2,477

Leases Leases (Tables)

Leases Leases (Tables)	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Schedule of Supplemental Balance Sheet Information for Operating Leases [Table Text Block]	As of December 31, Balance Sheet 2024 2023 Operating lease right-of-use assets $ 19,176 $ 24,131 Current maturities of operating lease liabilities $ 12,315 $ 11,032 Operating lease liabilities, net of current portion 29,686 38,850 Total lease liabilities $ 42,001 $ 49,882
Lease, Cost [Table Text Block]	Year Ended December 31, Lease Cost 2024 2023 2022 Operating lease cost $ 7,939 $ 8,514 $ 8,877 Short-term lease cost (1) 565 608 263 Variable lease costs 4,935 3,908 4,587 Sublease income (2,446) (2,157) (1,921) Net lease cost (2) $ 10,993 $ 10,873 $ 11,806 (1) Includes variable lease costs related to short-term leases. (2)
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	The table below summarizes the remaining expected lease payments under our operating leases as of December 31, 2024. Future Lease Payments December 31, 2025 $ 14,139 2026 12,920 2027 9,465 2028 5,907 2029 3,624 Thereafter 426 Total operating lease payments $ 46,481 Less: imputed interest (4,480) Present value of operating lease liabilities $ 42,001
Schedule of Supplemental Operating Lease Information [Table Text Block]	Year Ended December 31, Other Information 2024 2023 2022 Cash paid for operating lease liabilities $ 13,458 $ 13,107 $ 12,634 Operating lease right-of-use assets obtained in exchange for operating lease liabilities $ 4,286 $ 4,678 $ 1,908 Weighted average remaining lease term - operating leases 3.7 years 4.5 years 5.3 years Weighted average discount rate - operating leases 4.3 % 4.4 % 4.2 %

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment, net at December 31, 2024 and 2023 consisted of the following: As of December 31, 2024 2023 Computers, related equipment, and software $ 32,383 $ 40,174 Leasehold improvements 32,254 33,290 Furniture and fixtures 8,665 10,066 Assets under construction 1,617 866 Property and equipment 74,919 84,396 Accumulated depreciation (53,241) (60,668) Property and equipment, net $ 21,678 $ 23,728

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of Maturities of Long-Term Debt	A summary of the scheduled maturities of those borrowings follows: Scheduled Maturities of Long-Term Debt 2025 $ 13,750 2026 $ 13,750 2027 $ 330,187
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments	A summary of the carrying amounts of our debt follows: December 31, December 31, Revolver $ 93,000 $ 324,000 Term Loan 264,687 — Unamortized debt issuance costs - Term Loan 1 (1,080) — Total long-term debt 356,607 324,000 Current maturities of long-term debt (13,750) — Long-term debt, net of current portion $ 342,857 $ 324,000 (1) In connection with establishing the Term Loan, we incurred $1.4 million of debt issuance costs which were recognized as a discount to the Term Loan. These debt issuance costs are amortized to interest expense using an effective interest rate of 7.34% over the term of the Term Loan. Unamortized debt issuance costs related to the Revolver are included as a component of other non-current assets and amortized to interest expense using the straight-line method over the term of the Revolver.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Reconciliation of Basic and Diluted Earnings Per Share	Earnings per share under the basic and diluted computations are as follows: Year Ended December 31, 2024 2023 2022 Net income $ 116,626 $ 62,479 $ 75,552 Weighted average common shares outstanding—basic 17,894 18,832 20,249 Weighted average common stock equivalents 719 769 497 Weighted average common shares outstanding—diluted 18,613 19,601 20,746 Net income per basic share $ 6.52 $ 3.32 $ 3.73 Net income per diluted share $ 6.27 $ 3.19 $ 3.64
Summary of Anti-dilutive Securities Excluded from Computation of Weighted Average Common Stock Equivalents	The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above at December 31, 2024, 2023 and 2022 was less than 0.1 million, 0.1 million and 0.2 million, respectively, and related to unvested restricted stock and outstanding common stock options.

Restructuring Charges - (Tables

Restructuring Charges - (Tables)	12 Months Ended
	Dec. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Reserve by Type of Cost	The table below sets forth the changes in the carrying amount of our restructuring charge liability by restructuring type for the years ended December 31, 2024 and 2023. Employee Costs Other Total Balance as of December 31, 2022 $ 3,751 $ 568 $ 4,319 Additions (1) 2,991 — 2,991 Payments (5,376) (74) (5,450) Adjustments (1) — 41 41 Balance as of December 31, 2023 1,366 535 1,901 Additions (1) 2,864 355 3,219 Payments (3,601) (335) (3,936) Adjustments (1) — 13 13 Balance as of December 31, 2024 $ 629 $ 568 $ 1,197 (1) Additions and adjustments exclude non-cash items related to vacated office spaces, such as lease impairment charges and accelerated depreciation on abandoned operating lease ROU assets and fixed assets, which are recorded as restructuring charges on our consolidated statements of operations.

Derivative Instruments and He_3

Derivative Instruments and Hedging Activity (Tables)	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Value Interest Rate Swaps Designated as Cash Flow Hedging Instruments	The table below sets forth additional information relating to our derivative instruments as of December 31, 2024 and 2023. Derivative Instrument Balance Sheet Location December 31, 2024 December 31, 2023 Interest rate swaps Prepaid expenses and other current assets $ 1,600 $ 6,655 Interest rate swaps Other non-current assets 1,381 891 Total Assets $ 2,981 $ 7,546 Interest rate swaps Deferred compensation and other liabilities — 307 Foreign exchange forward contracts Accrued expenses and other current liabilities 381 70 Total Liabilities $ 381 $ 377

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	The tables below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2024 and 2023. Level 1 Level 2 Level 3 Total December 31, 2024 Assets: Interest rate swaps $ — $ 2,981 $ — $ 2,981 Convertible debt investment — — 62,344 62,344 Deferred compensation assets — 42,083 — 42,083 Total assets $ — $ 45,064 $ 62,344 $ 107,408 Liabilities: Foreign exchange forward contracts $ — $ 381 $ — $ 381 Contingent consideration for business acquisitions — — 221 221 Total liabilities $ — $ 381 $ 221 $ 602 December 31, 2023 Assets: Interest rate swaps $ — $ 7,546 $ — $ 7,546 Convertible debt investment — — 68,046 68,046 Deferred compensation assets — 34,826 — 34,826 Total assets $ — $ 42,372 $ 68,046 $ 110,418 Liabilities: Interest rate swaps $ — $ 307 $ — $ 307 Foreign exchange forward contracts — 70 — 70 Contingent consideration for business acquisitions — — 2,074 2,074 Total liabilities $ — $ 377 $ 2,074 $ 2,451
Convertible Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	The table below sets forth the changes in the balance of the convertible debt investment for the years ended December 31, 2024 and 2023. Convertible Debt Investment Balance as of December 31, 2022 $ 57,563 Change in fair value of convertible debt investment 10,483 Balance as of December 31, 2023 68,046 Change in fair value of convertible debt investment (5,702) Balance as of December 31, 2024 $ 62,344
Contingent Consideration Liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	The table below sets forth the changes in the balance of the contingent consideration for business acquisitions for the years ended December 31, 2024 and 2023. Contingent Consideration for Business Acquisitions Balance as of December 31, 2022 $ 3,190 Acquisition 374 Payment (1,000) Change in fair value (490) Balance as of December 31, 2023 2,074 Acquisition 36 Payment (1,356) Change in fair value (533) Balance as of December 31, 2024 $ 221

Other Comprehensive Income (L_2

Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Components of Accumulated Other Comprehensive Loss, Net of Tax	The table below sets forth the components of accumulated other comprehensive income (loss), net of tax for the years ended December 31, 2024, 2023, and 2022. Cash Flow Hedges (1) Foreign Available-for- Interest Rate Swaps Foreign Exchange Forward Contracts Total Balance as of December 31, 2021 $ (1,143) $ 18,374 $ (391) $ — $ 16,840 Foreign currency translation adjustment, net of tax of $0 (1,890) — — — (1,890) Unrealized gain (loss) on investments: Change in fair value, net of tax of $2,209 — (6,146) — — (6,146) Unrealized gain (loss) on cash flow hedges: Interest rate swaps: Change in fair value, net of tax of $(3,555) — — 9,892 — 9,892 Reclassification adjustment into earnings, net of tax of $176 — — (489) — (489) Foreign exchange forward contracts: Change in fair value, net of tax of $43 — — — (120) (120) Reclassification adjustment into earnings, net of tax of $(11) — — — 32 32 Balance as of December 31, 2022 (3,033) 12,228 9,012 (88) 18,119 Foreign currency translation adjustment, net of tax of $0 512 — — — 512 Unrealized gain (loss) on investments: Change in fair value, net of tax of $(2,672) — 7,811 — — 7,811 Unrealized gain (loss) on cash flow hedges: Interest rate swaps: Change in fair value, net of tax of $671 — — 2,068 — 2,068 Reclassification adjustment into earnings, net of tax of $2,020 — — (5,719) — (5,719) Foreign exchange forward contracts: Change in fair value, net of tax of $(13) — — — 34 34 Reclassification adjustment into earnings, net of tax of $(1) — — — 2 2 Balance as of December 31, 2023 (2,521) 20,039 5,361 (52) 22,827 Foreign currency translation adjustment, net of tax of $0 (3,391) — — — (3,391) Unrealized gain (loss) on investments: Change in fair value, net of tax of $1,525 — (4,177) — — (4,177) Unrealized gain (loss) on cash flow hedges: Interest rate swaps: Change in fair value, net of tax of $1,206 — — 3,468 — 3,468 Reclassification adjustment into earnings, net of tax of $2,323 — — (6,609) — (6,609) Foreign exchange forward contracts: Change in fair value, net of tax of $103 — — — (299) (299) Reclassification adjustment into earnings, net of tax of $(24) — — — 67 67 Balance as of December 31, 2024 $ (5,912) $ 15,862 $ 2,220 $ (284) $ 11,886 (1) The before tax amounts reclassified from accumulated other comprehensive income related to our interest rate swaps and foreign exchange forward contracts are recorded to interest expense, net of interest income and direct costs, respectively, on our consolidated statement of operations. The related tax amounts reclassified from accumulated other comprehensive income are recorded to income tax expense (benefit) on our consolidated statement of operations. Refer to Note 12 “Derivative Instruments and Hedging Activity” for additional information on our derivative instruments.

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Restricted Stock Activity	The table below summarizes the restricted stock activity for the year ended December 31, 2024. Number of Shares Weighted 2012 Omnibus Incentive Plan Stock Ownership Participation Program Total Nonvested restricted stock at December 31, 2023 926 17 943 $ 63.00 Granted 355 21 376 $ 98.94 Vested (388) (17) (405) $ 61.32 Forfeited (76) (2) (78) $ 77.14 Nonvested restricted stock at December 31, 2024 817 19 836 $ 78.68
Schedule of Performance-Based Stock Activity	The table below summarizes the performance-based stock activity for the year ended December 31, 2024. All nonvested performance-based stock outstanding at December 31, 2024 and 2023 was granted under the 2012 Omnibus Incentive Plan. Number of Weighted Nonvested performance-based stock at December 31, 2023 454 $ 60.72 Granted (1) 265 $ 99.40 Vested (264) $ 53.29 Forfeited (2) (34) $ 78.93 Nonvested performance-based stock at December 31, 2024 (3) 421 $ 78.27 (1) Shares granted in 2024 are presented at the stated target, which represents the base number of shares that could be earned. Actual shares earned may be below or, for certain grants, above the target based on the achievement of specific financial goals. (2) Forfeited shares include shares forfeited as a result of not meeting the performance criteria of the award as well as shares forfeited upon termination. (3) Of the 421,000 nonvested performance-based shares outstanding as of December 31, 2024, 327,236 shares were unearned and subject to achievement of specific financial goals. Once earned, the awards will be subject to time-based vesting according to the terms of the award. Based on 2024 financial results, approximately 67,451 of the 327,236 unearned shares will be forfeited in the first quarter of 2025.
Schedule of Share-based Payment Arrangement, Performance-Based Option, Valuation Assumptions [Table Text Block]	The fair values of the performance-based stock options granted during 2024 and 2023 were calculated using the Black-Scholes option pricing model using the following assumptions: 2024 2023 2022 Black-Scholes performance-based option pricing model: Expected dividend yield —% —% —% Expected volatility 40.0% 40.0% 40.0% Risk-free rate 4.2% 4.4% 1.6% / 2.6% Expected option life (in years) 4.5 years 4.5 years 4.5 years
Share-based Payment Arrangement, Performance-Based Option, Activity	Performance-based stock option activity for the year ended December 31, 2024 was as follows: Number Weighted Weighted Aggregate Outstanding at December 31, 2023 181 $ 63.73 5.5 $ 7.1 Granted (2) 42 $ 99.40 Exercised (33) $ 55.55 $ 1.6 Forfeited or expired (26) $ 76.90 Outstanding at December 31, 2024 (1)(3) 164 $ 72.44 5.0 $ 8.5 Exercisable at December 31, 2024 48 $ 59.82 4.5 $ 3.1 (1) All of the outstanding performance-based stock options were granted under the 2012 Omnibus Incentive Plan. (2) Performance-based stock options granted in 2024 are presented at the stated target, which represents the base number of options that could be earned. Actual options earned may be below or, for certain grants, above the target based on the achievement of specific financial goals. (3) Of the 164,000 outstanding performance-based stock options as of December 31, 2024, 39,327 were unearned and subject to achievement of specific financial goals. Once earned, the options will be subject to time-based vesting according to the terms of the award. Based on 2024 financial results, approximately 28,138 of the 39,327 unearned options will be forfeited in the first quarter of 2025.
Schedule of Stock Option Activity	Time-vested stock option activity for the year ended December 31, 2024 was as follows: Number Weighted Weighted Aggregate Outstanding at December 31, 2023 25 $ 52.49 4.7 $ 1.3 Granted — Exercised — Forfeited or expired — Outstanding at December 31, 2024 (1) 25 $ 52.49 3.8 $ 1.8 Exercisable at December 31, 2024 13 $ 52.49 3.8 $ 0.9 (1)

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Tax Expense for Continuing Operations	The income tax expense (benefit) for the years ended December 31, 2024, 2023, and 2022 consisted of the following: Year Ended December 31, 2024 2023 2022 Current taxes: Federal $ 18,345 $ 15,229 $ 7,130 State 7,645 5,816 2,987 Foreign 8,787 6,553 4,123 Total current expense 34,777 27,598 14,240 Deferred taxes: Federal 2,385 (4,516) 14,645 State 468 (936) 4,039 Foreign (240) (730) 101 Total deferred expense (benefit) 2,613 (6,182) 18,785 Income tax expense $ 37,390 $ 21,416 $ 33,025
Components of Income from Continuing Operations Before Income Tax Expense	The components of income before taxes were as follows: Year Ended December 31, 2024 2023 2022 U.S. $ 122,080 $ 63,935 $ 90,907 Foreign 31,936 19,960 17,670 Total $ 154,016 $ 83,895 $ 108,577
Reconciliation of Statutory Income Tax Rate to Our Effective Tax Rate for Continuing Operations	A reconciliation of the U.S. statutory income tax rate to our effective tax rate is as follows: Year Ended December 31, 2024 2023 2022 Percent of pretax income: At U.S. statutory tax rate 21.0 % 21.0 % 21.0 % State income taxes, net of federal benefit 4.8 5.8 6.1 Disallowed executive compensation 1.7 3.7 1.9 Valuation allowance 0.6 0.4 2.6 Disallowed meals and entertainment 0.6 0.9 0.1 Stock-based compensation (3.5) (2.9) 0.1 Tax credits (0.7) (1.8) (1.0) Realized investment losses/gains (0.6) (1.2) 1.4 Foreign source income (0.2) 0.2 1.2 Deferred tax adjustments — (0.3) (2.7) Other 0.6 (0.3) (0.3) Effective income tax rate 24.3 % 25.5 % 30.4 %
Net Deferred Tax Liabilities for Continuing Operations	The net deferred tax asset (liability) balance at December 31, 2024 and 2023 consisted of the following: As of December 31, 2024 2023 Deferred tax assets: Share-based compensation $ 13,216 $ 12,343 Operating lease liabilities 11,687 13,635 Deferred compensation liability 10,944 9,048 Accrued payroll and payroll related liabilities 10,086 4,541 Net operating loss carryforwards 3,553 3,508 Tax credits 2,164 1,609 Other 3,954 4,210 Total deferred tax assets 55,604 48,894 Valuation allowance (6,561) (5,679) Net deferred tax assets 49,043 43,215 Deferred tax liabilities: Intangibles and goodwill (51,526) (44,454) Operating lease right-of-use assets (5,756) (6,898) Convertible debt investment (5,542) (7,067) Prepaid expenses (4,811) (2,917) Property and equipment (1,448) (2,547) Other (5,860) (5,204) Total deferred tax liabilities (74,943) (69,087) Net deferred tax liabilities $ (25,900) $ (25,872)
Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits	A reconciliation of our beginning and ending amount of unrecognized tax benefits is as follows: Unrecognized Tax Benefits Balance at January 1, 2022 $ 744 Decrease due to lapse of statute of limitations (101) Decrease based on tax positions related to prior years (50) Balance at December 31, 2022 593 Decrease due to lapse of statute of limitations (593) Balance at December 31, 2023 — Balance at December 31, 2024 $ —

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Components of Segment Information	The tables below set forth information about our operating segments for the years ended December 31, 2024, 2023, and 2022, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements. We do not present financial information by geographic area because the financial results of our international operations are not significant to our consolidated financial statements. Year Ended December 31, 2024 2023 2022 Healthcare: Revenues before reimbursable expenses $ 756,263 $ 673,989 $ 534,999 Reimbursable expenses 21,174 22,324 16,347 Total revenues 777,437 696,313 551,346 Operating expenses: Direct costs 489,123 452,080 360,823 Reimbursable expenses 21,174 22,332 16,463 Selling, general and administrative expenses 49,728 41,351 36,155 Depreciation and amortization 7,162 6,373 6,015 Other segment items (1) 1,322 1,277 663 Total segment operating expenses 568,509 523,413 420,119 Segment operating income $ 208,928 $ 172,900 $ 131,227 Education: Revenues before reimbursable expenses $ 474,221 $ 429,663 $ 359,835 Reimbursable expenses 9,320 9,229 5,988 Total revenues 483,541 438,892 365,823 Operating expenses: Direct costs 337,607 308,800 257,603 Reimbursable expenses 9,320 9,311 6,083 Year Ended December 31, 2024 2023 2022 Selling, general and administrative expenses 25,472 21,128 18,795 Depreciation and amortization 1,912 437 492 Other segment items (1) 709 118 3,926 Total segment operating expenses 375,020 339,794 286,899 Segment operating income $ 108,521 $ 99,098 $ 78,924 Commercial: Revenues before reimbursable expenses $ 255,601 $ 258,408 $ 237,621 Reimbursable expenses 5,226 5,142 4,171 Total revenues 260,827 263,550 241,792 Operating expenses: Direct costs 183,250 181,812 167,398 Reimbursable expenses 5,223 5,123 4,126 Selling, general and administrative expenses 20,371 20,251 18,003 Depreciation and amortization 223 210 582 Other segment items (1) 562 1,952 1,658 Total segment operating expenses 209,629 209,348 191,767 Segment operating income $ 51,198 $ 54,202 $ 50,025 Total Huron: Revenues before reimbursable expenses $ 1,486,085 $ 1,362,060 $ 1,132,455 Reimbursable expenses 35,720 36,695 26,506 Total revenues $ 1,521,805 $ 1,398,755 $ 1,158,961 Segment operating income $ 368,647 $ 326,200 $ 260,176 Items not allocated at the segment level: Unallocated corporate expenses 191,180 175,206 136,677 Other gains, net (14,466) (444) (218) Restructuring charges 7,590 8,204 3,686 Depreciation and amortization 15,524 17,886 20,271 Operating income 168,819 125,348 99,760 Other income (expense), net (14,803) (41,453) 8,817 Income before taxes $ 154,016 $ 83,895 $ 108,577 (1) Other segment items in each segment primarily consists of restructuring charges for all periods presented.
Disaggregation of Revenue [Table Text Block]	he following tables illustrate the disaggregation of segment total revenues and segment revenues before reimbursable expenses by our two principal capabilities: i) Consulting and Managed Services and ii) Digital, and includes a reconciliation to consolidated total revenues and consolidated revenues before reimbursable expenses. We manage our business on the basis of revenues before reimbursable expenses, which we believe is the most accurate reflection of our services because it eliminates the effect of reimbursable expenses that we bill to our clients at cost. Year Ended December 31, Total Revenues by Capability 2024 2023 2022 Healthcare: Consulting and Managed Services $ 549,686 $ 493,263 $ 377,617 Digital 227,751 203,050 173,729 Total revenues $ 777,437 $ 696,313 $ 551,346 Education: Consulting and Managed Services $ 245,358 $ 219,098 $ 195,204 Digital 238,183 219,794 170,619 Total revenues $ 483,541 $ 438,892 $ 365,823 Commercial: Consulting and Managed Services $ 90,441 $ 92,182 $ 82,604 Digital 170,386 171,368 159,188 Total revenues $ 260,827 $ 263,550 $ 241,792 Total Huron: Consulting and Managed Services $ 885,485 $ 804,543 $ 655,425 Digital 636,320 594,212 503,536 Total revenues $ 1,521,805 $ 1,398,755 $ 1,158,961 Year Ended December 31, Revenues before Reimbursable Expenses by Capability 2024 2023 2022 Healthcare: Consulting and Managed Services $ 533,846 $ 476,726 $ 365,645 Digital 222,417 197,263 169,354 Total revenues before reimbursable expenses $ 756,263 $ 673,989 $ 534,999 Education: Consulting and Managed Services $ 240,985 $ 214,971 $ 192,336 Digital 233,236 214,692 167,499 Total revenues before reimbursable expenses $ 474,221 $ 429,663 $ 359,835 Commercial: Consulting and Managed Services $ 89,028 $ 90,323 $ 80,013 Digital 166,573 168,085 157,608 Total revenues before reimbursable expenses $ 255,601 $ 258,408 $ 237,621 Total Huron: Consulting and Managed Services $ 863,859 $ 782,020 $ 637,994 Digital 622,226 580,040 494,461 Total revenues before reimbursable expenses $ 1,486,085 $ 1,362,060 $ 1,132,455

Valuation and Qualifying Acco_2

Valuation and Qualifying Accounts (Tables)	12 Months Ended
	Dec. 31, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Summary of Allowances for Doubtful Accounts and Unbilled Services and Valuation Allowance for Deferred Tax Assets	The table below sets forth the changes in the carrying amount of our allowances for doubtful accounts and unbilled services and valuation allowance for deferred tax assets for the years ended December 31, 2024, 2023, and 2022. Allowances for doubtful accounts and unbilled services includes allowances for fee adjustments and other discretionary pricing adjustments as well as allowances related to clients' inability to make required payments on accounts receivable. Beginning Additions (1) Deductions Ending Year ended December 31, 2022: Allowances for doubtful accounts and unbilled services $ 15,795 17,820 11,480 $ 22,135 Valuation allowance for deferred tax assets $ 2,876 3,421 630 $ 5,667 Year ended December 31, 2023: Allowances for doubtful accounts and unbilled services $ 22,135 30,570 23,461 $ 29,244 Valuation allowance for deferred tax assets $ 5,667 239 227 $ 5,679 Year ended December 31, 2024: Allowances for doubtful accounts and unbilled services $ 29,244 24,520 35,346 $ 18,418 Valuation allowance for deferred tax assets $ 5,679 1,035 153 $ 6,561 (1)

Description of Business (Detail

Description of Business (Details)	12 Months Ended
	Dec. 31, 2024 Segment
Accounting Policies [Abstract]
Number of Reportable Segments	3

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) Reporting_Unit Segment Billing	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Cash and Cash Equivalents [Line Items]
Number of billing arrangements for revenue recognition | Billing	4
Capitalized Contract Cost, Amortization	$ 300	$ 200	$ 300
Capitalized Contract Cost, Net	500	400
Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, before Accumulated Amortization	7,700	7,200
Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, Accumulated Amortization	3,000	2,200
Hosting Arrangement, Service Contract, Implementation Cost, Expense, Amortization	$ 800	700	1,200
Number of Reporting Units | Reporting_Unit	3
Sponsorship and advertising costs	$ 10,200	7,300	6,300
Foreign Currency Transaction Gain (Loss), Realized	$ (2,100)	(500)	(700)
Number of Operating Segments | Segment	3
Restructuring charges	$ 9,913	11,550	9,909
Other Restructuring [Member]
Cash and Cash Equivalents [Line Items]
Restructuring charges	$ 500		1,700
Other Restructuring [Member] | Abandoned Capitalized Software Development Project
Cash and Cash Equivalents [Line Items]
Restructuring charges			300
Maximum [Member]
Cash and Cash Equivalents [Line Items]
Cash and Cash Equivalent maturity period	3 months
Computers, related equipment and software [Member] | Minimum [Member]
Cash and Cash Equivalents [Line Items]
Property, Plant and Equipment, Useful Life	2 years
Computers, related equipment and software [Member] | Maximum [Member]
Cash and Cash Equivalents [Line Items]
Property, Plant and Equipment, Useful Life	4 years
Furniture and fixtures [Member]
Cash and Cash Equivalents [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Software and Software Development Costs
Cash and Cash Equivalents [Line Items]
Capitalized Computer Software, Gross	$ 700
Capitalized Computer Software, Accumulated Amortization	100
Amortized capitalized software development costs	100
Internal Use Software
Cash and Cash Equivalents [Line Items]
Capitalized Computer Software, Gross	94,300	72,300
Capitalized Computer Software, Accumulated Amortization	33,800	26,800
Amortized capitalized software development costs	$ 7,600	$ 6,500	$ 5,900

Acquisitions & Divestitures (De

Acquisitions & Divestitures (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Business Combination Segment Allocation [Line Items]
Loss on disposal	$ 4,309	$ 0	$ 0
Healthcare | Studer Education
Business Combination Segment Allocation [Line Items]
Loss on disposal	$ 3,600

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Changes in Carrying Amount of Goodwill (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill [Line Items]
Goodwill	$ 1,134,635	$ 1,081,603	$ 1,080,858
Accumulated impairment losses	(455,892)	(455,892)	(455,892)
Goodwill recorded in connection with business combinations	55,479	745
Goodwill, Written off Related to Sale of Business Unit	(2,300)
Goodwill, Foreign Currency Translation Gain (Loss)	(147)
Goodwill, net beginning balance	625,711	624,966
Goodwill	678,743	625,711	624,966
Loss on disposal	4,309	0	0
Education [Member]
Goodwill [Line Items]
Goodwill	145,981	123,652	123,652
Accumulated impairment losses	(1,417)	(1,417)	(1,417)
Goodwill recorded in connection with business combinations	22,476	0
Goodwill, Written off Related to Sale of Business Unit	0
Goodwill, Foreign Currency Translation Gain (Loss)	(147)
Goodwill, net beginning balance	122,235	122,235
Goodwill	144,564	122,235	122,235
Commercial
Goodwill [Line Items]
Goodwill	345,102	312,968	312,968
Accumulated impairment losses	(264,451)	(264,451)	(264,451)
Goodwill recorded in connection with business combinations	32,134	0
Goodwill, Written off Related to Sale of Business Unit	0
Goodwill, Foreign Currency Translation Gain (Loss)	0
Goodwill, net beginning balance	48,517	48,517
Goodwill	80,651	48,517	48,517
Healthcare
Goodwill [Line Items]
Goodwill	643,552	644,983	644,238
Accumulated impairment losses	(190,024)	(190,024)	(190,024)
Goodwill recorded in connection with business combinations	869	745
Goodwill, Foreign Currency Translation Gain (Loss)	0
Goodwill, net beginning balance	454,959	454,214
Goodwill	453,528	$ 454,959	$ 454,214
Healthcare | Studer Education
Goodwill [Line Items]
Goodwill, Written off Related to Sale of Business Unit	(2,300)
Loss on disposal	$ 3,600

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Intangible assets
Gross carrying amount	$ 55,656	$ 83,586
Accumulated Amortization	29,580	65,512
Customer relationships [Member]
Intangible assets
Gross carrying amount	30,683	60,636
Accumulated Amortization	$ 9,790	48,928
Customer relationships [Member] | Minimum [Member]
Intangible assets
Finite-Lived Intangible Asset, Useful Life	5 years
Customer relationships [Member] | Maximum [Member]
Intangible assets
Finite-Lived Intangible Asset, Useful Life	10 years
Technology-Based Intangible Assets [Member]
Intangible assets
Gross carrying amount	$ 16,230	16,230
Accumulated Amortization	$ 12,771	10,195
Technology-Based Intangible Assets [Member] | Minimum [Member]
Intangible assets
Finite-Lived Intangible Asset, Useful Life	2 years
Technology-Based Intangible Assets [Member] | Maximum [Member]
Intangible assets
Finite-Lived Intangible Asset, Useful Life	5 years
Trade names [Member]
Intangible assets
Finite-Lived Intangible Asset, Useful Life	6 years
Gross carrying amount	$ 6,000	6,000
Accumulated Amortization	6,000	6,000
Customer Contracts
Intangible assets
Gross carrying amount	1,483	0
Accumulated Amortization	$ 418	0
Customer Contracts | Minimum [Member]
Intangible assets
Finite-Lived Intangible Asset, Useful Life	2 years
Customer Contracts | Maximum [Member]
Intangible assets
Finite-Lived Intangible Asset, Useful Life	4 years
Non-competition Agreements [Member]
Intangible assets
Gross carrying amount	$ 1,260	720
Accumulated Amortization	$ 601	$ 389
Non-competition Agreements [Member] | Minimum [Member]
Intangible assets
Finite-Lived Intangible Asset, Useful Life	2 years
Non-competition Agreements [Member] | Maximum [Member]
Intangible assets
Finite-Lived Intangible Asset, Useful Life	5 years

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Amortization (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Finite-Lived Intangible Assets, Amortization Expense, Year Two	$ 7,632
Finite-Lived Intangible Assets, Amortization Expense, Year Three	5,882
Finite-Lived Intangible Assets, Amortization Expense, Year Five	4,480
Finite-Lived Intangible Assets, Amortization Expense, after Year Five	3,606
Finite-Lived Intangible Assets, Amortization Expense, after Year Five	$ 2,477

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) Reporting_Unit	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Goodwill [Line Items]
Goodwill	$ 678,743	$ 625,711	$ 624,966
Number of Reporting Units | Reporting_Unit	3
Acquired Finite-Lived Intangible Assets [Line Items]	$ 14,600	2,900
Finite Lived Intangible Asset Fully Amortized and Retired	42,400	14,100
Amortization of Intangible Assets	$ 6,500	$ 8,200	$ 11,200
Healthcare
Goodwill [Line Items]
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount	105%
Education [Member]
Goodwill [Line Items]
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount	185%
Commercial
Goodwill [Line Items]
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount	335%

Leases Schedule of Operating Le

Leases Schedule of Operating Lease Balances (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Operating lease right-of-use assets	$ 19,176	$ 24,131
Current maturities of operating lease liabilities	12,315	11,032
Operating lease liabilities, net of current portion	29,686	38,850
Operating Lease, Liability	$ 42,001	$ 49,882

Leases Schedule of Lease Costs

Leases Schedule of Lease Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Operating Lease, Cost	$ 7,939	$ 8,514	$ 8,877
Short-term Lease, Cost	565	608	263
Variable Lease, Cost	4,935	3,908	4,587
Sublease Income	(2,446)	(2,157)	(1,921)
Lease, Cost	$ 10,993	$ 10,873	$ 11,806

Leases Schedule of Maturities o

Leases Schedule of Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months	$ 14,139
Lessee, Operating Lease, Liability, Payments, Due Year Two	12,920
Lessee, Operating Lease, Liability, Payments, Due Year Three	9,465
Lessee, Operating Lease, Liability, Payments, Due Year Four	5,907
Lessee, Operating Lease, Liability, Payments, Due Year Five	3,624
Lessee, Operating Lease, Liability, Payments, Due after Year Five	426
Operating Lease, Payments	46,481
Operating Lease, Liability	42,001	$ 49,882
Lessee Operating Lease Liability Undiscounted Excess	$ (4,480)

Leases Schedule of Operating _2

Leases Schedule of Operating Lease Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Operating Lease, Payments	$ 13,458	$ 13,107	$ 12,634
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$ 4,286	$ 4,678	$ 1,908
Operating Lease, Weighted Average Remaining Lease Term	3 years 8 months 12 days	4 years 6 months	5 years 3 months 18 days
Operating Lease, Weighted Average Discount Rate, Percent	4.30%	4.40%	4.20%

Leases Leases Additional Inform

Leases Leases Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Lessee, Lease, Description [Line Items]
Lease, Cost	$ 10,993	$ 10,873	$ 11,806
Impairment of Long-Lived Assets Held-for-use	3,500	6,300
Office Space Reductions [Member]
Lessee, Lease, Description [Line Items]
Impairment of Long-Lived Assets Held-for-use	2,700	5,400
Office Space Reductions [Member] | Fixed Assets
Lessee, Lease, Description [Line Items]
Impairment of Long-Lived Assets Held-for-use	700	1,400
Office Space Reductions [Member] | Operating lease right-of-use asset [Member]
Lessee, Lease, Description [Line Items]
Impairment of Long-Lived Assets Held-for-use	2,000	4,000
Additional Impairment on Previously Vacated Office Spaces
Lessee, Lease, Description [Line Items]
Impairment of Long-Lived Assets Held-for-use		900	200
Additional Impairment on Previously Vacated Office Spaces | Fixed Assets
Lessee, Lease, Description [Line Items]
Impairment of Long-Lived Assets Held-for-use	700	500
Additional Impairment on Previously Vacated Office Spaces | Operating lease right-of-use asset [Member]
Lessee, Lease, Description [Line Items]
Impairment of Long-Lived Assets Held-for-use	$ 100	400
Minimum [Member]
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Renewal Term	1 year
Maximum [Member]
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Renewal Term	10 years
Restructuring Charges [Member]
Lessee, Lease, Description [Line Items]
Lease, Cost	$ 2,200	$ 1,800	$ 2,000

Property and Equipment, Net - A

Property and Equipment, Net - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Depreciation expense for property and equipment	$ 10.6	$ 10.2	$ 10.3
Restructuring and Related Cost, Accelerated Depreciation	$ 0.5	$ 0.1

Property and Equipment, Net - S

Property and Equipment, Net - Summary of Premises and Equipment (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property and equipment	$ 74,919	$ 84,396
Accumulated depreciation and amortization	(53,241)	(60,668)
Property and equipment, net	21,678	23,728
Computers, related equipment and software [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	32,383	40,174
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	32,254	33,290
Furniture and fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	8,665	10,066
Assets under Construction [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	$ 1,617	$ 866

Financing Arrangements - Summar

Financing Arrangements - Summary of Carrying Amounts of Debt (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Long-term debt, net of current portion	$ 342,857	$ 324,000

Financing Arrangements - Additi

Financing Arrangements - Additional Information (Detail)	1 Months Ended
	Feb. 29, 2024 USD ($)	Dec. 31, 2024 USD ($)	Feb. 01, 2024 USD ($)	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
Outstanding letters of credit		$ 400,000		$ 500,000
Long-term debt, net of current portion		342,857,000		$ 324,000,000
Long-Term Debt, Gross		357,700,000
Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Line of credit current borrowing capacity		$ 600,000,000
Percentage of weighted average interest rate of borrowings		4.70%		4.20%
Unused borrowing capacity under Credit Agreement		$ 506,600,000
Senior Secured Credit Facility [Member] | Minimum [Member] | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.125%
Senior Secured Credit Facility [Member] | Minimum [Member] | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1.125%
Senior Secured Credit Facility [Member] | Maximum [Member] | Base Rate [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.875%
Senior Secured Credit Facility [Member] | Maximum [Member] | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1.875%
Term Debt Credit Facility
Debt Instrument [Line Items]
Debt Instrument, Periodic Payment, Principal	$ 3,400,000
Loans Payable			$ 275,000,000
Term Debt Credit Facility | Minimum [Member] | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1.625%
Term Debt Credit Facility | Maximum [Member] | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	2.375%
Credit Facility
Debt Instrument [Line Items]
Commitment Fee Rate Increase/Decrease from KPIs	0.01%
Interest Rate or LOC Increase/Decrease from KPIs	0.05%
Optional increase In revolver	$ 250,000,000
Percentage of pledged voting stock in domestic subsidiaries	100%
Percentage of pledged voting stock in foreign subsidiaries	65%
Maximum consolidated leverage ratio	3.75
Debt Instrument, Covenant, Consolidated Leverage Ratio, Additional Increase	4.25
Minimum interest coverage ratio			3
Actual consolidated leverage ratio		1.39
Actual interest coverage ratio		10.50
Debt Instrument, Maturity Date	Nov. 15, 2027
Maximum Borrowing Capacity			$ 1,130,000,000
Percentage of Pledged Voting Stock in Foreign Subsidiary not Entitled to Vote	1

Financing Arrangements - Long-T

Financing Arrangements - Long-Term (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Debt Instrument [Line Items]
Long-Term Debt, Maturity, Year One	$ 13,750
Long-Term Debt, Maturity, Year Two	13,750
Long-Term Debt, Maturity, Year Three	$ 330,187

Financing Arrangements - Carryi

Financing Arrangements - Carrying Amounts (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Feb. 01, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Long-Term Debt, Current Maturities	$ (13,750)		$ 0
Long-term debt, net of current portion	342,857		324,000
Debt Issuance Costs, Gross		$ 1,400
Term Debt Credit Facility
Debt Instrument [Line Items]
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	(1,080)		0
Long-Term Debt	264,687		0
Debt Instrument, Interest Rate, Effective Percentage		7.34%
Credit Facility
Debt Instrument [Line Items]
Long-Term Debt	356,607		324,000
Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Long-Term Debt	$ 93,000		$ 324,000

Capital Structure - Additional

Capital Structure - Additional Information (Detail) - $ / shares	Dec. 31, 2024	Dec. 31, 2023
Equity [Abstract]
Preferred stock, shares authorized	50,000,000
Preferred Stock, Shares Issued	0	0
Common stock, shares authorized	500,000,000	500,000,000
Common stock, par value (in USD per share)	$ 0.01	$ 0.01

Revenues Revenue - Additional I

Revenues Revenue - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenues	$ 1,521,805	$ 1,398,755	$ 1,158,961
Contract with Customer, Performance Obligation Satisfied in Previous Period	26,300	10,900	7,600
Revenue, Remaining Performance Obligation, Amount	187,600
Contract with Customer, Asset, after Allowance for Credit Loss	60,100	70,100
Contract Asset, Period Increase (Decrease)	10,000
Deferred revenues	26,900	22,500
Deferred Revenue, Period Increase (Decrease)	4,400
Deferred Revenue, Revenue Recognized	21,900	21,300
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	80,400
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	56,300
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	50,900
Change in Estimated Variable Consideration [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Contract with Customer, Performance Obligation Satisfied in Previous Period	22,800	9,600	5,300
Release of Allowance [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Contract with Customer, Performance Obligation Satisfied in Previous Period	$ 3,500	$ 1,300	$ 2,300

Revenues Performance Obligation

Revenues Performance Obligations Information (Details) $ in Millions	Dec. 31, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 187.6
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 80.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 56.3
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 50.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	5 years

Earnings Per Share - Reconcilia

Earnings Per Share - Reconciliation of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Earnings Per Share Reconciliation [Abstract]
Net Income (Loss)	$ 116,626	$ 62,479	$ 75,552
Weighted average common shares outstanding-basic	17,894	18,832	20,249
Weighted average common stock equivalents	719	769	497
Weighted average common shares outstanding- diluted	18,613	19,601	20,746
Net income per basic share	$ 6.52	$ 3.32	$ 3.73
Net income per diluted share	$ 6.27	$ 3.19	$ 3.64

Earnings Per Share - Summary of

Earnings Per Share - Summary of Anti-dilutive Securities Excluded from Computation of Weighted Average Common Stock Equivalents (Detail) - shares shares in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities	0.1	0.1	0.2

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Nov. 30, 2020
Accelerated Share Repurchases [Line Items]
Share Repurchase Program, Expiration Date	Dec. 31, 2025
Share Repurchase Program, Excise Tax, Payable		$ 900,000
Share Repurchase Program, Excise Tax	$ 500,000
Stock Repurchased and Retired During Period, Value	122,198,000	123,627,000	$ 121,308,000
Share Repurchases Initiated but not yet Settled	636,000	$ 1,030,000	$ 1,107,000
Share Repurchase Program
Accelerated Share Repurchases [Line Items]
Share repurchase authorized amount	$ 500,000,000				$ 50,000,000
Shares repurchased	1,218,434	1,461,815	2,037,752
Stock Repurchased and Retired During Period, Value	$ 122,200,000	$ 123,600,000	$ 121,300,000
Share Repurchases Initiated but not yet Settled	$ 600,000	$ 1,000,000	$ 1,100,000	$ 200,000
Share Repurchases Initiated but not yet Settled, Shares	5,103	10,000	15,200	3,820
Share Repurchase Program, Remaining Authorized, Amount	$ 64,500,000

Restructuring Charges - Additio

Restructuring Charges - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Restructuring Charges [Line Items]
Restructuring additions	$ 9,913	$ 11,550	$ 9,909
Loss on disposal	4,309	0	0
Restructuring charge liability	1,197	1,901	4,319
Studer Education
Restructuring Charges [Line Items]
Restructuring additions	1,300
Loss on disposal	3,600
Employee Severance [Member]
Restructuring Charges [Line Items]
Restructuring additions	3,300	3,000	5,700
Restructuring charge liability	629	1,366	3,751
Employee Severance [Member] | Contract Termination
Restructuring Charges [Line Items]
Restructuring additions	2,300
Employee Severance [Member] | Studer Education
Restructuring Charges [Line Items]
Restructuring additions	1,000
Office Space Reductions [Member]
Restructuring Charges [Line Items]
Restructuring additions	6,200	8,100	2,500
Office Space Reductions [Member] | Q1 2023 Hillsboro Office Exit Member
Restructuring Charges [Line Items]
Restructuring additions		1,900
Office Space Reductions [Member] | Q3 2023 Lexington Office Exit
Restructuring Charges [Line Items]
Restructuring additions		3,500
Office Space Reductions [Member] | Office Space Reductions that were Initiated in Prior Periods
Restructuring Charges [Line Items]
Restructuring additions	2,300	1,800	2,300
Office Space Reductions [Member] | Additional Impairment on Previously Vacated Office Spaces
Restructuring Charges [Line Items]
Restructuring additions	800	900	200
Office Space Reductions [Member] | 200 S. Michigan Ave Office Exit
Restructuring Charges [Line Items]
Restructuring additions	1,400
Office Space Reductions [Member] | New York, NY Office Exit
Restructuring Charges [Line Items]
Restructuring additions	1,200
Office Space Reductions [Member] | Abandoned fixed assets accelerated amortization
Restructuring Charges [Line Items]
Restructuring additions	500
Other Restructuring [Member]
Restructuring Charges [Line Items]
Restructuring additions	500		1,700
Restructuring charge liability	568	535	568
Other Restructuring [Member] | Contract Termination
Restructuring Charges [Line Items]
Restructuring additions			600
Other Restructuring [Member] | Studer Education
Restructuring Charges [Line Items]
Restructuring additions	300
Other Restructuring [Member] | Abandoned Capitalized Software Development Project
Restructuring Charges [Line Items]
Restructuring additions			300
Other Restructuring [Member] | San Francisco Office [Member]
Restructuring Charges [Line Items]
Restructuring additions			700
Education [Member]
Restructuring Charges [Line Items]
Restructuring additions	400	100	3,900
Corporate Segment
Restructuring Charges [Line Items]
Restructuring additions	7,600	8,200	3,700
Commercial
Restructuring Charges [Line Items]
Restructuring additions	600	2,000	1,600
Commercial | Other Restructuring [Member] | hurn_Life Sciences Divestiture Gain/Loss | Life Sciences
Restructuring Charges [Line Items]
Restructuring additions			100
Healthcare
Restructuring Charges [Line Items]
Restructuring additions	$ 1,300	$ 1,300	$ 700

Restructuring Charges Restructu

Restructuring Charges Restructuring Charges - Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Restructuring Reserve [Roll Forward]
Restructuring reserve, period start	$ 1,901	$ 4,319
Restructuring additions	3,219	2,991
Payments for restructuring	(3,936)	(5,450)
Restructuring reserve adjustments	13	41
Restructuring reserve, period end	1,197	1,901
Other Restructuring [Member]
Restructuring Reserve [Roll Forward]
Restructuring reserve, period start	535	568
Restructuring additions	355	0
Payments for restructuring	(335)	(74)
Restructuring reserve adjustments	13	41
Restructuring reserve, period end	568	535
Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring reserve, period start	1,366	3,751
Restructuring additions	2,864	2,991
Payments for restructuring	(3,601)	(5,376)
Restructuring reserve adjustments	0	0
Restructuring reserve, period end	$ 629	$ 1,366

Derivative Instruments and He_4

Derivative Instruments and Hedging Activity - Additional Information (Detail) ₨ in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2024 INR (₨)	Dec. 31, 2023 USD ($)	Dec. 31, 2023 INR (₨)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Duration of SOFR	1 month
Interest Rate Swap [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest rate swap agreement for a notional amount	$ 250		$ 250
Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net	$ 1.2
Loss reclassification from accumulated OCI to income, estimate of time to transfer	12 months
Interest rate swap agreement, end date	Jan. 31, 2029
Foreign Exchange Contract
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest rate swap agreement for a notional amount	$ 16.3	₨ 1,400	$ 16.6	₨ 1,380
Loss reclassification from accumulated OCI to income, estimate of time to transfer	12 months
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	$ (0.3)
Interest rate swap agreement, end date	Dec. 31, 2025

Derivative Instruments and He_5

Derivative Instruments and Hedging Activities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Derivatives, Fair Value [Line Items]
Cash Flow Hedge Derivative Instrument Assets at Fair Value	$ 2,981	$ 7,546
Cash Flow Hedge Derivative Instrument Liabilities at Fair Value	381	377
Prepaid Expenses and Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Fair value (derivative asset and liability)	1,600	6,655
Other Noncurrent Assets [Member]
Derivatives, Fair Value [Line Items]
Fair value (derivative asset and liability)	1,381	891
Other Noncurrent Liabilities [Member]
Derivatives, Fair Value [Line Items]
Fair value (derivative asset and liability)	0	307
Accrued Liabilities [Member]
Derivatives, Fair Value [Line Items]
Foreign Currency Cash Flow Hedge Liability at Fair Value	$ 381	$ 70

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Assets, Fair Value Disclosure [Abstract]
Assets, Fair Value Disclosure	$ 107,408	$ 110,418
Financial and Nonfinancial Liabilities, Fair Value Disclosure	602	2,451
Deferred Compensation Plan Assets [Member]
Assets, Fair Value Disclosure [Abstract]
Assets, Fair Value Disclosure	42,083	34,826
Contingent Consideration Liability [Member]
Assets, Fair Value Disclosure [Abstract]
Financial and Nonfinancial Liabilities, Fair Value Disclosure	221	2,074	$ 3,190
Interest Rate Swap [Member]
Assets, Fair Value Disclosure [Abstract]
Assets, Fair Value Disclosure	2,981	7,546
Financial and Nonfinancial Liabilities, Fair Value Disclosure		307
Foreign Exchange Contract
Assets, Fair Value Disclosure [Abstract]
Financial and Nonfinancial Liabilities, Fair Value Disclosure	381	70
Convertible Debt Securities [Member]
Assets, Fair Value Disclosure [Abstract]
Assets, Fair Value Disclosure	62,344	68,046	$ 57,563
Fair Value, Inputs, Level 2 [Member]
Assets, Fair Value Disclosure [Abstract]
Assets, Fair Value Disclosure	45,064	42,372
Financial and Nonfinancial Liabilities, Fair Value Disclosure	381	377
Fair Value, Inputs, Level 2 [Member] | Deferred Compensation Plan Assets [Member]
Assets, Fair Value Disclosure [Abstract]
Assets, Fair Value Disclosure	42,083	34,826
Fair Value, Inputs, Level 2 [Member] | Interest Rate Swap [Member]
Assets, Fair Value Disclosure [Abstract]
Assets, Fair Value Disclosure	2,981	7,546
Financial and Nonfinancial Liabilities, Fair Value Disclosure		307
Fair Value, Inputs, Level 2 [Member] | Foreign Exchange Contract
Assets, Fair Value Disclosure [Abstract]
Financial and Nonfinancial Liabilities, Fair Value Disclosure	381	70
Fair Value, Inputs, Level 3 [Member]
Assets, Fair Value Disclosure [Abstract]
Assets, Fair Value Disclosure	62,344	68,046
Financial and Nonfinancial Liabilities, Fair Value Disclosure	221	2,074
Fair Value, Inputs, Level 3 [Member] | Contingent Consideration Liability [Member]
Assets, Fair Value Disclosure [Abstract]
Financial and Nonfinancial Liabilities, Fair Value Disclosure	221	2,074
Fair Value, Inputs, Level 3 [Member] | Convertible Debt Securities [Member]
Assets, Fair Value Disclosure [Abstract]
Assets, Fair Value Disclosure	$ 62,344	$ 68,046

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Additional Information (Detail) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2019 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term Investments	$ 75,414		$ 69,712	$ 75,414
Debt and Equity Securities, Unrealized Gain (Loss)			$ 0	$ (26,262)	$ 26,964
Contingent Consideration Liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Instrument, Measurement Input	0.063		0.056	0.063
Convertible Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Instrument, Maturity Date			Jan. 17, 2027
Convertible Debt Securities [Member] | Shorelight Holdings Llc [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term Investments			$ 40,900
Debt Instrument, Interest Rate, Stated Percentage			1.69%
Convertible Debt Securities [Member] | Shorelight Holdings Llc [Member] | Measurement Input, Price Volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Instrument, Measurement Input	0.350		0.400	0.350
Convertible Debt Securities [Member] | Shorelight Holdings Llc [Member] | Measurement Input, Discount Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Instrument, Measurement Input	0.245		0.235	0.245
Preferred Stock [Member] | Medically Home Group Inc. [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term Investments						$ 5,000
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount	$ 26,300
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount			$ 26,300
Equity Securities without Readily Determinable Fair Value, Amount	$ 7,400		7,400	$ 7,400
Debt and Equity Securities, Unrealized Gain (Loss)		$ 27,000
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount			$ 28,600

Fair Value of Financial Instr_6

Fair Value of Financial Instruments Fair Value of Financial Instruments - Convertible Debt Investment Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	$ 107,408	$ 110,418
Convertible Debt Securities [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	62,344	68,046	$ 57,563
Shorelight Holdings Llc [Member] | Convertible Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)	$ (5,702)	$ 10,483

Fair Value of Financial Instr_7

Fair Value of Financial Instruments Fair Value of Financial Instruments - Contingent Consideration Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial and Nonfinancial Liabilities, Fair Value Disclosure	$ 602	$ 2,451
Contingent Consideration Liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability	36	374
Contingent Consideration Liability [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial and Nonfinancial Liabilities, Fair Value Disclosure	221	2,074	$ 3,190
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements	(1,356)	(1,000)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)	$ (533)	$ (490)

Other Comprehensive Income (L_3

Other Comprehensive Income (Loss) - Components of Accumulated Other Comprehensive Loss, Net of Tax (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign currency translation adjustments, beginning balance	$ (2,521)	$ (3,033)	$ (1,143)
Unrealized loss on investment, beginning balance	20,039	12,228	18,374
Unrealized gain (loss) on investment, net of tax	(4,177)	7,811	(6,146)
Accumulated other comprehensive income	11,886	22,827	18,119	$ 16,840
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax	(3,391)	512	(1,890)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax	(5,912)	(2,521)	(3,033)	(1,143)
AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax	15,862	20,039	12,228	18,374
Accumulated other comprehensive income	11,886	22,827	18,119	16,840
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Tax	0	0	0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax	(3,391)	512	(1,890)
Unrealized gain (loss) on investment, net of tax	(4,177)	7,811	(6,146)
Other Comprehensive Income (Loss), Securities, Available-for-sale, Tax	1,525	(2,672)	2,209
Foreign Exchange Contract
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax	(284)	(52)	(88)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	(299)	34	(120)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(67)	2	32
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	(299)	34	(120)
AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax	(284)	(52)	(88)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(67)	2	32
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax	103	(13)	43
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	(24)	(1)	(11)
Interest Rate Swap [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax	2,220	5,361	9,012	(391)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	3,468	2,068	9,892
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	6,609	5,719	489
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	3,468	2,068	9,892
AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax	2,220	5,361	9,012	$ (391)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	6,609	5,719	489
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax	1,206	671	(3,555)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	$ 2,323	$ 2,020	$ 176

Employee Benefit and Deferred_2

Employee Benefit and Deferred Compensation Plans - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Postemployment Benefits [Abstract]
Employer contributions up to percent of employee's salaries	6%
Employer matching contributions	$ 41	$ 37	$ 31.2
Deferred compensation liability	$ 42.3	$ 34.7

Equity Incentive Plans - Schedu

Equity Incentive Plans - Schedule of Restricted Stock Activity (Detail) - Restricted Stock Awards [Member] - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Total
Nonvested stock, number of shares, beginning balance	943
Granted, number of shares	376
Vested, number of shares	(405)
Forfeited, number of shares	(78)
Nonvested stock, number of shares, ending balance	836	943
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 78.68	$ 63
Weighted average grant date fair value (in USD per share)	98.94	$ 80.84	$ 49.69
Vested, weighted average grant date fair value (in USD per share)	61.32
Forfeited, weighted average grant date fair value (in USD per share)	77.14
Nonvested stock, weighted average grant date fair value, beginning balance (in USD per share)	$ 63
Two Thousand And Twelve Plan [Member]
Total
Nonvested stock, number of shares, beginning balance	926
Granted, number of shares	355
Vested, number of shares	(388)
Forfeited, number of shares	(76)
Nonvested stock, number of shares, ending balance	817	926
Stock Ownership Participation Program [Member]
Total
Nonvested stock, number of shares, beginning balance	17
Granted, number of shares	21
Vested, number of shares	(17)
Forfeited, number of shares	(2)
Nonvested stock, number of shares, ending balance	19	17

Equity Incentive Plans - Sche_2

Equity Incentive Plans - Schedule of Performance-Based Stock Activity (Detail) - Performance-based stock activity [Member] - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Number of Shares
Nonvested stock, number of shares, beginning balance	421,000	454,000
Granted, number of shares		265,000
Vested, number of shares		(264,000)
Forfeited, number of shares		(34,000)
Nonvested stock, number of shares, ending balance		421,000	454,000
Nonvested And Unearned Performance Shares		327,236
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Nonvested stock, weighted average grant date fair value, beginning balance (in USD per share)	$ 78.27	$ 60.72
Weighted average grant date fair value (in USD per share)		99.40	$ 80.89	$ 48.22
Vested, weighted average grant date fair value (in USD per share)		53.29
Forfeited, weighted average grant date fair value (in USD per share)		78.93
Nonvested stock, weighted average grant date fair value, ending balance (in USD per share)		$ 78.27	$ 60.72
Forecast [Member]
Number of Shares
Forfeited, number of shares	(67,451)

Equity Incentive Plans - Sche_3

Equity Incentive Plans - Schedule of Performance-Based Option Activity (Details) - Performance-based stock options - USD ($) $ / shares in Units, $ in Millions					3 Months Ended	12 Months Ended
	Mar. 01, 2024	Mar. 01, 2023	Apr. 01, 2022	Mar. 01, 2022	Mar. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate						0%	0%	0%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate						40%	40%	40%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	4.20%	4.40%	2.60%	1.60%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term						4 years 6 months	4 years 6 months	4 years 6 months
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number						164,000	181,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross						42,000
Exercise of stock options, shares						(33,000)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period						(26,000)
Exercisable, shares, ending balance						48,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price						$ 72.44	$ 63.73
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price						99.40
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price						55.55
Nonvested And Unearned Performance Shares						76.90
Exercisable, weighted average exercise price (in USD per share)						$ 59.82
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Weighted-average remaining contractual term (years), option outstanding						5 years	5 years 6 months
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value						$ 8.5	$ 7.1
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value						$ 1.6
Weighted-average remaining contractual term (years), options exercisable						4 years 6 months
Aggregate intrinsic value, options exercisable, ending balance						$ 3.1
Nonvested and Unearned Performance Stock Options						39,327
Forecast [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Nonvested And Unearned Performance Shares					28,138

Equity Incentive Plans - Sche_4

Equity Incentive Plans - Schedule of Time-Vested Stock Option Activity (Detail) - Time Vested Stock Option [Member] - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	25	25
Exercisable, weighted average exercise price (in USD per share)	$ 52.49
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0
Exercise of stock options, shares	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period	0
Weighted-average remaining contractual term (years), options exercisable	3 years 9 months 18 days
Aggregate intrinsic value, options exercisable, ending balance	$ 0.9
Exercisable, shares, ending balance	13
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 52.49	$ 52.49
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Weighted-average remaining contractual term (years), option outstanding	3 years 9 months 18 days	4 years 8 months 12 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 1.8	$ 1.3

Equity Incentive Plans - Additi

Equity Incentive Plans - Additional Information (Detail) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($) $ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Retirement eligible provision, minimum age	62 years
Retirement eligible provision, minimum years of service	7 years
Share-based compensation expense	$ 45.1	$ 45.7	$ 31
Income tax benefits	9.4	9.3	6.8
Unrecognized compensation cost	$ 64.4
Unrecognized Compensation Costs for Nonvested Share-Based Awards Weighted Average Period	2.8
Share-Based Payment Arrangement, Accelerated Cost	$ 0.5
Restricted Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	4 years
Aggregate fair value of stock vested	$ 40.3	$ 27.6	$ 18.4
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares	$ 98.94	$ 80.84	$ 49.69
Performance-based stock activity [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	2 years
Aggregate fair value of stock vested	$ 25.9	$ 5.9	$ 5.8
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares	$ 99.40	$ 80.89	$ 48.22
Performance-based stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	2 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value	$ 1.6
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares	$ 39.10	$ 32.27	$ 17
Weighted-average remaining contractual term (years), options exercisable	4 years 6 months
Time Vested Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining contractual term (years), options exercisable	3 years 9 months 18 days
Share-based Payment Arrangement, Option [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options contractual term	10 years
Share-based Payment Arrangement, Option [Member] | Performance-based stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value		$ 0.8
Share-based Payment Arrangement, Option [Member] | Time Vested Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	4 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value		$ 1.5	$ 0.5
Time Vested Stock Option [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options contractual term	7 years
Performance-based stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options contractual term	7 years
Two Thousand And Twelve Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for issuance | shares	800,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized | shares	5,400,000
Stock Ownership Participation Program [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for issuance | shares	200,000
Restricted stock granted as a percentage of purchased shares	0.25
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized | shares	900,000

Income Taxes - Income Tax Expen

Income Taxes - Income Tax Expense for Continuing Operations (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Current:
Federal	$ 18,345	$ 15,229	$ 7,130
State	7,645	5,816	2,987
Foreign	8,787	6,553	4,123
Total current	34,777	27,598	14,240
Deferred:
Federal	2,385	(4,516)	14,645
State	468	(936)	4,039
Foreign	(240)	(730)	101
Total deferred expense (benefit)	2,613	(6,182)	18,785
Income tax expense for continuing operations	$ 37,390	$ 21,416	$ 33,025

Income Taxes - Components of In

Income Taxes - Components of Income from Continuing Operations Before Income Tax Expense (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
U.S.	$ 122,080	$ 63,935	$ 90,907
Foreign	31,936	19,960	17,670
Income before taxes	$ 154,016	$ 83,895	$ 108,577

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of Statutory Income Tax Rate to Our Effective Tax Rate for Continuing Operations (Detail)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
At U.S. statutory tax rate	21%	21%	21%
State income taxes, net of federal benefit	4.80%	5.80%	6.10%
Effective Income Tax Rate Reconciliation, Disallowed Executive Compensation, Percent	1.70%	3.70%	1.90%
Valuation allowance	0.60%	0.40%	2.60%
Tax credits / Section 199 Deduction	(0.60%)	(0.90%)	(0.10%)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent	(3.50%)	(2.90%)	0.10%
Effective Income Tax Rate Reconciliation, Tax Credit, Percent	(0.70%)	(1.80%)	(1.00%)
Effective Income Tax Rate Reconciliation, Realized Investment (Gains) Losses, Percent	(0.60%)	(1.20%)	1.40%
Foreign source income	(0.20%)	0.20%	1.20%
Effective Tax Rate Reconciling Item, Deferred Tax Adjustments	0%	(0.30%)	(2.70%)
Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent	0.60%	(0.30%)	(0.30%)
Effective income tax expense rate for continuing operations	24.30%	25.50%	30.40%

Income Taxes - Net Deferred Tax

Income Taxes - Net Deferred Tax Liabilities for Continuing Operations (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Deferred tax assets:
Share-based compensation	$ 13,216	$ 12,343
Deferred tax asset, operating lease liabilities	11,687	13,635
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits	10,944	9,048
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation	10,086	4,541
Net operating loss carry-forwards	3,553	3,508
At U.S. statutory tax rate	2,164	1,609
Deferred Tax Assets, Other	3,954	4,210
Total deferred tax assets	55,604	48,894
Deferred Tax Assets, Valuation Allowance	(6,561)	(5,679)
Net deferred tax assets	49,043	43,215
Deferred tax liabilities:
Deferred Tax Liabilities, Goodwill and Intangible Assets	51,526	44,454
Deferred Tax Liabilities, Leasing Arrangements	(5,756)	(6,898)
Deferred Tax Liabilities, Investments	(5,542)	(7,067)
Deferred Tax Liabilities, Prepaid Expenses	(4,811)	(2,917)
Deferred Tax Liabilities, Property, Plant and Equipment	(1,448)	(2,547)
Other	(5,860)	(5,204)
Total deferred tax liabilities	(74,943)	(69,087)
Deferred Tax Assets, Net	$ (25,900)	$ (25,872)

Income Taxes - Reconciliation_2

Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2024	Jan. 01, 2022
Unrecognized Tax Benefits [Roll Forward]
Unrecognized tax benefits, beginning balance	$ 593
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations	(593)	$ (101)
Decrease based on tax positions related to the prior year		(50)
Unrecognized tax benefits, ending balance	0	593
Unrecognized Income Tax Benefits	$ 0	$ 593	$ 0	$ 744

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Income Tax Disclosure [Line Items]
Deferred Tax Assets, Valuation Allowance	$ 6,561	$ 5,679
Tax Credit Carryforward, Amount	$ 2,200
Tax Credit Carryforward, Expiration Date	Dec. 31, 2030
Foreign[Member]
Income Tax Disclosure [Line Items]
Operating Loss Carryforwards	$ 3,500
Income Tax Examination Period	2019 through 2023
Operating Loss Carryforwards, Expiration Date	Dec. 31, 2027
State and Local Jurisdiction [Member]
Income Tax Disclosure [Line Items]
Income Tax Examination Period	2018 through 2023
Federal [Member]
Income Tax Disclosure [Line Items]
Income Tax Examination Period	2021 through 2023

Commitments, Contingencies an_2

Commitments, Contingencies and Guarantees - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Commitments And Contingencies [Line Items]
Gain (Loss) from Litigation Settlement	$ 15,000
Guarantees in the form of letters of credit	400	$ 500
Proceeds from Legal Settlements	15,000
Fair Value, Recurring [Member]
Commitments And Contingencies [Line Items]
Financial and Nonfinancial Liabilities, Fair Value Disclosure	602	2,451
Contingent Consideration Liability [Member] | Fair Value, Recurring [Member]
Commitments And Contingencies [Line Items]
Financial and Nonfinancial Liabilities, Fair Value Disclosure	221	2,074	$ 3,190
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member]
Commitments And Contingencies [Line Items]
Financial and Nonfinancial Liabilities, Fair Value Disclosure	221	2,074
Fair Value, Inputs, Level 3 [Member] | Contingent Consideration Liability [Member] | Fair Value, Recurring [Member]
Commitments And Contingencies [Line Items]
Financial and Nonfinancial Liabilities, Fair Value Disclosure	$ 221	$ 2,074

Segment Information - Additiona

Segment Information - Additional Information (Detail) - Segment	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting [Abstract]
Number of Operating Segments	3
receivables from major customer percentage	10%	10%
Revenue generated by major client percentage	10%	10%	10%

Segment Information - Component

Segment Information - Components of Segment Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Components of Segment Information
Revenues before reimbursable expenses	$ 1,486,085	$ 1,362,060	$ 1,132,455
Reimbursable expenses	(35,720)	(36,695)	(26,506)
Revenues	1,521,805	1,398,755	1,158,961
Direct costs (exclusive of depreciation and amortization included below)	1,010,077	942,697	785,881
Reimbursable expenses	35,715	36,766	26,671
Selling, general and administrative expenses	286,655	257,932	209,574
Depreciation and amortization expense	24,822	24,906	27,359
Total operating expenses	1,352,986	1,273,407	1,059,201
Operating income (loss)	168,819	125,348	99,760
Other gains, net	14,196	444	193
Restructuring charges	9,913	11,550	9,909
Interest expense, net of interest income	(25,347)	(19,573)	(11,883)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	154,016	83,895	108,577
Healthcare
Components of Segment Information
Revenues before reimbursable expenses	756,263	673,989	534,999
Revenues	777,437	696,313	551,346
Restructuring charges	1,300	1,300	700
Education [Member]
Components of Segment Information
Revenues before reimbursable expenses	474,221	429,663	359,835
Revenues	483,541	438,892	365,823
Restructuring charges	400	100	3,900
Commercial
Components of Segment Information
Revenues before reimbursable expenses	255,601	258,408	237,621
Revenues	260,827	263,550	241,792
Restructuring charges	600	2,000	1,600
Operating Segments [Member]
Components of Segment Information
Revenues before reimbursable expenses	1,486,085	1,362,060	1,132,455
Reimbursable expenses	(35,720)	(36,695)	(26,506)
Revenues	1,521,805	1,398,755	1,158,961
Operating income (loss)	368,647	326,200	260,176
Operating Segments [Member] | Healthcare
Components of Segment Information
Revenues before reimbursable expenses	756,263	673,989	534,999
Reimbursable expenses	(21,174)	(22,324)	(16,347)
Revenues	777,437	696,313	551,346
Direct costs (exclusive of depreciation and amortization included below)	489,123	452,080	360,823
Reimbursable expenses	21,174	22,332	16,463
Selling, general and administrative expenses	49,728	41,351	36,155
Depreciation and amortization expense	7,162	6,373	6,015
Segment Reporting, Other Item Amount	1,322	1,277	663
Total operating expenses	568,509	523,413	420,119
Operating income (loss)	208,928	172,900	131,227
Operating Segments [Member] | Education [Member]
Components of Segment Information
Revenues before reimbursable expenses	474,221	429,663	359,835
Reimbursable expenses	(9,320)	(9,229)	(5,988)
Revenues	483,541	438,892	365,823
Direct costs (exclusive of depreciation and amortization included below)	337,607	308,800	257,603
Reimbursable expenses	9,320	9,311	6,083
Selling, general and administrative expenses	25,472	21,128	18,795
Depreciation and amortization expense	1,912	437	492
Segment Reporting, Other Item Amount	709	118	3,926
Total operating expenses	375,020	339,794	286,899
Operating income (loss)	108,521	99,098	78,924
Operating Segments [Member] | Commercial
Components of Segment Information
Revenues before reimbursable expenses	255,601	258,408	237,621
Reimbursable expenses	(5,226)	(5,142)	(4,171)
Revenues	260,827	263,550	241,792
Direct costs (exclusive of depreciation and amortization included below)	183,250	181,812	167,398
Reimbursable expenses	5,223	5,123	4,126
Selling, general and administrative expenses	20,371	20,251	18,003
Depreciation and amortization expense	223	210	582
Segment Reporting, Other Item Amount	562	1,952	1,658
Total operating expenses	209,629	209,348	191,767
Operating income (loss)	51,198	54,202	50,025
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]
Components of Segment Information
Depreciation and amortization expense	15,524	17,886	20,271
Operating income (loss)	168,819	125,348	99,760
Other operating expenses and gains	191,180	175,206	136,677
Other gains, net	(14,466)	(444)	(218)
Restructuring charges	7,590	8,204	3,686
Interest expense, net of interest income	(14,803)	(41,453)	8,817
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$ 154,016	$ 83,895	$ 108,577

Segment Information Segment Inf

Segment Information Segment Information - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Revenues	$ 1,521,805	$ 1,398,755	$ 1,158,961
Revenues before reimbursable expenses	1,486,085	1,362,060	1,132,455
Consulting And Managed Services Capability
Disaggregation of Revenue [Line Items]
Revenues	885,485	804,543	655,425
Revenues before reimbursable expenses	863,859	782,020	637,994
Digital Capability
Disaggregation of Revenue [Line Items]
Revenues	636,320	594,212	503,536
Revenues before reimbursable expenses	622,226	580,040	494,461
Healthcare
Disaggregation of Revenue [Line Items]
Revenues	777,437	696,313	551,346
Revenues before reimbursable expenses	756,263	673,989	534,999
Healthcare | Consulting And Managed Services Capability
Disaggregation of Revenue [Line Items]
Revenues	549,686	493,263	377,617
Revenues before reimbursable expenses	533,846	476,726	365,645
Healthcare | Digital Capability
Disaggregation of Revenue [Line Items]
Revenues	227,751	203,050	173,729
Revenues before reimbursable expenses	222,417	197,263	169,354
Education [Member]
Disaggregation of Revenue [Line Items]
Revenues	483,541	438,892	365,823
Revenues before reimbursable expenses	474,221	429,663	359,835
Education [Member] | Consulting And Managed Services Capability
Disaggregation of Revenue [Line Items]
Revenues	245,358	219,098	195,204
Revenues before reimbursable expenses	240,985	214,971	192,336
Education [Member] | Digital Capability
Disaggregation of Revenue [Line Items]
Revenues	238,183	219,794	170,619
Revenues before reimbursable expenses	233,236	214,692	167,499
Commercial
Disaggregation of Revenue [Line Items]
Revenues	260,827	263,550	241,792
Revenues before reimbursable expenses	255,601	258,408	237,621
Commercial | Consulting And Managed Services Capability
Disaggregation of Revenue [Line Items]
Revenues	90,441	92,182	82,604
Revenues before reimbursable expenses	89,028	90,323	80,013
Commercial | Digital Capability
Disaggregation of Revenue [Line Items]
Revenues	170,386	171,368	159,188
Revenues before reimbursable expenses	$ 166,573	$ 168,085	$ 157,608

Valuation and Qualifying Acco_3

Valuation and Qualifying Accounts - Summary of Allowances for Doubtful Accounts and Unbilled Services and Valuation Allowance for Deferred Tax Assets (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Allowances for doubtful accounts and unbilled services [Member]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning balance	$ 29,244	$ 22,135	$ 15,795
Additions	24,520	30,570	17,820
Deductions	35,346	23,461	11,480
Ending balance	18,418	29,244	22,135
Valuation allowance for deferred tax assets [Member]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning balance	5,679	5,667	2,876
Additions	1,035	239	3,421
Deductions	153	227	630
Ending balance	$ 6,561	$ 5,679	$ 5,667